BARNES GROUP INC - Quarter Report: 2020 September (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-4801

BARNES GROUP INC.

(Exact name of registrant as specified in its charter)

Delaware

06-0247840

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

123 Main Street

Bristol

Connecticut

06010

(Address of Principal Executive Offices)

(Zip Code)

(860) 583-7070

Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

Common Stock, par value $0.01 per share

New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes

☐

☒

The registrant had outstanding 50,617,373 shares of common stock as of October 21, 2020.

Barnes Group Inc.

Index to Form 10-Q

For the Quarterly Period Ended September 30, 2020


		Page
Part I.	FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)	3
	Consolidated Statements of Income for the three and nine months ended Sep tember 30, 2020 and 2019	3
	Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2020 and 2019	4
	Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019	5
	Consolidated Statements of Cash Flows for the nine months ended Septemb er 30, 2020 and 2019	6
	Notes to Consolidated Financial Statements	7
	Report of Independent Registered Public Accounting Firm	26

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	27

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	39

Item 4.	Controls and Procedures	39

Part II.	OTHER INFORMATION

Item 1.	Legal Proceedings	41

Item 1A.	Risk Factors	41

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	41

Item 6.	Exhibits	43

	Signatures	44
	Exhibit Index	45

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. See “FORWARD-LOOKING STATEMENTS” under Part I - Item 2 “Management's Discussion and Analysis of Financial Condition and Results of Operations” of this Quarterly Report on Form 10-Q.

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

BARNES GROUP INC.

CONSOLIDATED STATEMENTS OF INCOME

(Dollars in thousands, except per share data)

(Unaudited)


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		2020		2019
Net sales	$	269,059	$	372,587	$	835,266	$	1,120,947

Cost of sales	176,908		234,421		532,214		717,370
Selling and administrative expenses	60,908		70,581		212,380		228,385
	237,816		305,002		744,594		945,755
Operating income	31,243		67,585		90,672		175,192

Interest expense	3,701		5,344		11,924		15,856
Other expense (income), net	47		2,524		2,700		6,043
Income before income taxes	27,495		59,717		76,048		153,293
Income taxes	12,137		13,948		30,390		35,916


Net income	$	15,358	$	45,769	$	45,658	$	117,377

Per common share:
Basic	$	0.30	$	0.90	$	0.90	$	2.29
Diluted	0.30		0.89		0.89		2.27

Weighted average common shares outstanding:
Basic	50,833,157		50,926,521		50,886,094		51,276,801
Diluted	50,937,093		51,230,845		51,123,024		51,718,574

See accompanying notes.

BARNES GROUP INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in thousands)

(Unaudited)


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		2020		2019
Net income	$	15,358	$	45,769	$	45,658	$	117,377
Other comprehensive income (loss), net of tax
Unrealized gain (loss) on hedging activities, net of tax ⁽¹⁾	79		(168)		(1,447)		(1,960)
Foreign currency translation adjustments, net of tax ⁽²⁾	39,851		(39,289)		23,774		(44,513)
Defined benefit pension and other postretirement benefits, net of tax ⁽³⁾	2,209		2,112		2,667		5,648
Total other comprehensive income (loss), net of tax	42,139		(37,345)		24,994		(40,825)
Total comprehensive income	$	57,497	$	8,424	$	70,652	$	76,552

(1) Net of tax of $73 and $(52) for the three months ended September 30, 2020 and 2019, respectively, and $(481) and $(607) for the nine months ended September 30, 2020 and 2019, respectively.

(2) Net of tax of $0 and $(196) for the three months ended September 30, 2020 and 2019, respectively, and $(66) and $(230) for the nine months ended September 30, 2020 and 2019, respectively.

(3) Net of tax of $844 and $554 for the three months ended September 30, 2020 and 2019, respectively, and $456 and $1,663 for the nine months ended September 30, 2020 and 2019, respectively.

See accompanying notes.

BARNES GROUP INC.

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share data)

(Unaudited)


	September 30, 2020		December 31, 2019
Assets
Current assets
Cash and cash equivalents	$	77,485	$	93,805
Accounts receivable, less allowances (2020 - $6,273; 2019 - $5,197)	248,053		348,974
Inventories	245,968		232,706
Prepaid expenses and other current assets	77,209		67,532
Assets held for sale	—		21,373
Total current assets	648,715		764,390

Deferred income taxes	23,202		21,235

Property, plant and equipment	870,088		840,640
Less accumulated depreciation	(516,824)		(484,037)
	353,264		356,603

Goodwill	969,255		933,022
Other intangible assets, net	560,466		581,116
Other assets	55,214		53,924
Assets held for sale	—		28,045
Total assets	$	2,610,116	$	2,738,335

Liabilities and Stockholders' Equity
Current liabilities
Notes and overdrafts payable	$	14,490	$	7,724
Accounts payable	91,959		118,509
Accrued liabilities	208,948		209,992
Long-term debt - current	1,820		2,034
Liabilities held for sale	—		4,616
Total current liabilities	317,217		342,875

Long-term debt	701,413		825,017
Accrued retirement benefits	90,597		93,358
Deferred income taxes	89,505		88,408
Long-term tax liability	59,063		66,012
Other liabilities	44,665		45,148
Liabilities held for sale	—		6,989

Commitments and contingencies (Note 16)
Stockholders' equity
Common stock - par value $0.01 per share Authorized: 150,000,000 shares Issued: at par value (2020 - 64,141,290 shares; 2019 - 63,872,756 shares)	641		639
Additional paid-in capital	499,020		489,282
Treasury stock, at cost (2020 - 13,526,172 shares; 2019 - 13,051,256 shares)	(516,800)		(498,074)
Retained earnings	1,510,296		1,489,176
Accumulated other non-owner changes to equity	(185,501)		(210,495)
Total stockholders' equity	1,307,656		1,270,528
Total liabilities and stockholders' equity	$	2,610,116	$	2,738,335

See accompanying notes.

BARNES GROUP INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)


	Nine Months Ended September 30,
	2020		2019
Operating activities:
Net income	$	45,658	$	117,377
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	66,045		75,692

(Gain) loss on disposition of property, plant and equipment	(303)		35
Stock compensation expense	8,094		9,740
Seeger divestiture charges	6,620		—
Changes in assets and liabilities, net of the effects of divestitures:
Accounts receivable	103,161		9,741
Inventories	(11,616)		6,145
Prepaid expenses and other current assets	(10,168)		(12,494)
Accounts payable	(24,476)		(19,541)
Accrued liabilities	(7,981)		(216)
Deferred income taxes	(5,032)		(2,617)
Long-term retirement benefits	(2,517)		(16,862)
Long-term tax liability	(6,949)		(6,949)
Other	2,871		1,298
Net cash provided by operating activities	163,407		161,349

Investing activities:
Proceeds from disposition of property, plant and equipment	580		233
Proceeds from the sale of businesses, net of cash sold	36,879		—
Investment in restricted cash	(6,621)		—
Capital expenditures	(30,170)		(37,722)
Business acquisitions, net of cash acquired	—		(6,061)


Net cash provided (used) by investing activities	668		(43,550)

Financing activities:
Net change in other borrowings	6,794		16,415
Payments on long-term debt	(194,279)		(290,593)
Proceeds from the issuance of long-term debt	50,000		230,625


Proceeds from the issuance of common stock	1,661		2,458
Common stock repurchases	(15,550)		(50,347)
Dividends paid	(24,302)		(24,414)
Withholding taxes paid on stock issuances	(3,177)		(5,913)
Other	(2,217)		(13,034)
Net cash used by financing activities	(181,070)		(134,803)

Effect of exchange rate changes on cash flows	675		(3,247)
Decrease in cash and cash equivalents	(16,320)		(20,251)
Cash and cash equivalents at beginning of period	93,805		100,719
Cash and cash equivalents at end of period	$	77,485	$	80,468

See accompanying notes.

BARNES GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(All dollar amounts included in the notes are stated in thousands except per share data)

(Unaudited)

1. Basis of Presentation

The accompanying unaudited consolidated balance sheet and the related unaudited consolidated statements of income, comprehensive income and cash flows have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. The consolidated financial statements do not include all information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. The balance sheet as of December 31, 2019 has been derived from the 2019 financial statements of Barnes Group Inc. (the “Company”). For additional information, please refer to the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. In the opinion of management, all adjustments, including normal recurring accruals considered necessary for a fair statement of the results, have been included. Operating results for the nine-month period ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.

The outbreak and a continued spread of COVID-19 has resulted in a substantial curtailment of business activities worldwide and has caused weakened economic conditions, both in the United States and abroad. COVID-19 has had, and may continue to have, a significant negative impact on the Company's ongoing operations and the end markets in which it serves. The Company has assessed the impacts that COVID-19 has had on its accounting estimates, assumptions and disclosures.

2. Divestiture

On December 20, 2019, the Company entered into a Share Purchase and Transfer Agreement ("SPA") with the Kajo Neukirchen Group ("KNG") to sell the Seeger business, consisting of partnership interests and shares, respectively, of Seeger-Orbis GmbH & Co. OHG and Seeger-Orbis Mechanical Components (Tianjin) Co., Ltd. (“Seeger”) for 42,500 Euros, subject to certain adjustments. The Company classified the assets and liabilities of Seeger, which operated within the Industrial segment, as "held for sale" on the Consolidated Balance Sheet as of December 31, 2019. Pursuant to the required accounting guidance, the Company allocated $15,000 of goodwill from the Engineered Components reporting unit to Seeger based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained. The Company subsequently recorded an impairment charge of $5,600 related to the goodwill that was allocated to Seeger. The impairment charge was recorded within Selling and Administrative expenses on the Consolidated Statements of Income in the period ended December 31, 2019.

The Seeger assets and liabilities held for sale were comprised of the following as of December 31, 2019:


Assets
Accounts receivable, less allowance of $152	$	6,844
Inventories	13,727
Prepaid expenses and other current assets	802
Current assets held for sale	21,373

Property, plant and equipment, net	17,701
Other intangible assets, net	590
Goodwill	9,400
Other assets	354
Non-current assets held for sale	28,045

Liabilities
Accounts payable	$	2,961
Accrued liabilities	1,655
Current liabilities held for sale	4,616

Accrued retirement benefits	5,788
Other liabilities	1,201
Non-current liabilities held for sale	6,989

The Company completed the sale of the Seeger business to KNG effective February 1, 2020. Gross proceeds received were 39,634 Euros ($43,732). The Company yielded net cash proceeds of $36,879 after consideration of cash sold and transaction costs. The final amount of proceeds from the sale is subject to post-closing adjustments. Resulting tax charges of $4,211 were recognized in the first quarter of 2020 following the completion of the sale. Divestiture charges of $2,409 resulted from the completion of the sale and were recorded within Selling and Administrative expenses on the Consolidated Statements of Income in the quarter ended March 31, 2020.

The Company utilized the proceeds from the sale to reduce debt under the Amended Credit Facility. Pursuant to the SPA, 6,000 Euros of the proceeds were placed in escrow and will be released pro-ratably through 2024, pending any potential settlement of claims. Cash related to a pending claim would remain in escrow until a final determination of the claim has been made. The Company has recorded the restricted cash in other assets as of September 30, 2020.

3. Recent Accounting Standards

The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under U.S. GAAP through the use of Accounting Standards Updates ("ASUs") to the FASB's Accounting Standards Codification. The Company evaluates the applicability and potential impacts of recent ASUs on its Consolidated Financial Statements and related disclosures.

Recently Adopted Accounting Standards

In February 2016, the FASB amended its guidance related to lease accounting. The amended guidance required lessees to recognize a majority of their leases on the balance sheet as a right-of-use ("ROU") asset and a lease liability. The guidance was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption was permitted. The Company adopted the new standard using the modified retrospective approach on January 1, 2019. The most significant impact of the guidance was the recognition of ROU assets and related lease liabilities for operating leases on the Consolidated Balance Sheet. The Company recognized ROU assets and related lease liabilities of $31,724 and $32,579, respectively, related to operating lease commitments as of January 1, 2019. The amended guidance did not have a material impact on the Company's cash flows or results of operations.

In June 2016, the FASB amended its guidance related to credit losses on financial instruments. The amended guidance requires the use of a methodology of estimation that reflects expected credit losses on certain types of financial instruments, including trade receivables, as a replacement to the current methodology, which estimates losses based on incurred credit losses. This expected credit loss methodology requires that the Company consider a broader range of information when estimating credit losses on receivables. The amended guidance was effective for fiscal years, and interim periods within those years, beginning

after December 15, 2019. The Company adopted this amended guidance and applicable FASB updates related to the guidance during the first quarter of 2020 and it did not have a material impact on the Company's Consolidated Financial Statements.

In January 2017, the FASB amended its guidance related to goodwill impairment testing. The amended guidance simplified the subsequent measurement of goodwill, eliminating Step 2 from the goodwill impairment test. Under the amended guidance, companies should perform their annual goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. Companies would recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, assuming the loss recognized does not exceed the total amount of goodwill for the reporting unit. The amended guidance was effective for fiscal years beginning after December 15, 2019. Early adoption was permitted. The Company elected to early adopt this amended guidance during the second quarter of 2018 in connection with its annual goodwill impairment testing and it did not have an impact on the Company's Consolidated Financial Statements.

In August 2017, the FASB amended its guidance related to hedge accounting. The amended guidance made more financial and nonfinancial hedging strategies eligible for hedge accounting, amended presentation and disclosure requirements and changed the assessment of effectiveness. The guidance also more closely aligned hedge accounting with management strategies, simplified application and increased the transparency of hedging. The amended guidance was effective January 1, 2019, with early adoption permitted in any interim period. The Company adopted the amended guidance on January 1, 2019 and it did not have a material impact on the Company's Consolidated Financial Statements, however it did result in amendments to certain disclosures required pursuant to the earlier guidance. See Note 10 of the Company's Consolidated Financial Statements.

In August 2018, the FASB issued new guidance related to a customer's accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by a vendor (for example, a service contract). Pursuant to the new guidance, customers apply the same criteria for capitalizing implementation costs in a hosting arrangement as they would for an arrangement that has a software license. The new guidance was effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption was permitted, including adoption in any interim period for which financial statements have not been issued. The FASB provided the option of applying the guidance retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company elected to early adopt this guidance, prospectively, during the third quarter of 2018, and it did not have a material impact on the Consolidated Financial Statements.

Recently Issued Accounting Standards

In August 2018, the FASB amended its guidance related to disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The amended requirements serve to remove, add and otherwise clarify certain existing disclosures. The amended guidance is effective for fiscal years ending after December 15, 2020. The guidance requires application on a retrospective basis to all periods presented. The adoption of this amended guidance is not expected to have a material impact on the Company's Consolidated Financial Statements.

In December 2019, the FASB amended its guidance related to income taxes. The amended guidance simplifies the accounting for income taxes, eliminating certain exceptions to the general income tax principles, in an effort to reduce the cost and complexity of application. The amended guidance is effective for annual periods beginning after December 15, 2020, and interim periods within those reporting periods. Early adoption is permitted in any interim or annual period. The guidance requires application on either a prospective, retrospective or modified retrospective basis, contingent on the income tax exception being applied. The adoption of this amended guidance is not expected to have a material impact on the Company's Consolidated Financial Statements.

The United Kingdom's Financial Conduct Authority, which regulates the London Interbank Offered Rate (“LIBOR”), announced its intent to phase out the use of LIBOR by the end of 2021. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, identified the Secured Overnight Financing Rate (“SOFR”) as its preferred benchmark alternative to U.S. dollar LIBOR. Published by the Federal Reserve Bank of New York, SOFR represents a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is calculated based on directly observable U.S. Treasury-backed repurchase transactions. In March 2020, in response to this transition, the FASB issued guidance that provides optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedging relationships and other transactions that reference LIBOR, and addresses operational issues likely to arise in modifying contracts to replace discontinued reference rates with new rates. The guidance is effective as of March 12, 2020 through December 31, 2022. Once elected, the guidance must be applied prospectively for all eligible contract modifications. The Company’s Amended Credit Agreement and corresponding interest rate swap are tied to LIBOR, with both maturing in early 2022 (see Note 9). The Company is evaluating the potential impact of the replacement of LIBOR, but does not anticipate a material impact on our business, financial condition, results of operations or cash flows.

4. Revenue

The Company is a global provider of highly engineered products, differentiated industrial technologies, and innovative solutions, serving a wide range of end markets and customers. Its specialized products and services are used in far-reaching applications including aerospace, transportation, manufacturing, automation, healthcare and packaging.

Revenue is recognized by the Company when control of the product or solution is transferred to the customer. Control is generally transferred when products are shipped or delivered to customers, title is transferred, and the significant risks and rewards of ownership have transferred, and the Company has rights to payment and rewards of ownership pass to the customer. Customer acceptance may also be a factor in determining whether control of the product has transferred. Although revenue is generally transferred at a point in time, a certain portion of businesses with customized products or contracts in which the Company performs work on customer-owned assets requires the use of an over time recognition model as certain contracts meet one or more of the established criteria pursuant to the accounting guidance. Also, service revenue is recognized as control transfers, which is concurrent with the services being performed.

The following table presents the Company's revenue disaggregated by products and services, and geographic regions, by segment:


	Three Months Ended September 30, 2020										Nine Months Ended September 30, 2020
	Industrial		Aerospace		Total Company		Industrial		Aerospace		Total Company
Products and Services
Engineered Components Products	$	41,746	$	—	$	41,746	$	115,414	$	—	$	115,414
Molding Solutions Products	103,684		—		103,684		294,869		—		294,869
Force & Motion Control Products	37,813		—		37,813		112,250		—		112,250
Automation Products	13,668		—		13,668		38,506		—		38,506
Aerospace Original Equipment Manufacturer Products	—		52,023		52,023		—		178,346		178,346
Aerospace Aftermarket Products and Services	—		20,125		20,125		—		95,881		95,881
	$	196,911	$	72,148	$	269,059	$	561,039	$	274,227	$	835,266

Geographic Regions ^(A)
Americas	$	73,677	$	56,740	$	130,417	$	208,232	$	196,945	$	405,177
Europe	80,470		10,139		90,609		230,685		49,742		280,427
Asia	41,255		4,704		45,959		118,511		23,937		142,448
Rest of World	1,509		565		2,074		3,611		3,603		7,214
	$	196,911	$	72,148	$	269,059	$	561,039	$	274,227	$	835,266


	Three Months Ended September 30, 2019										Nine Months Ended September 30, 2019
	Industrial		Aerospace		Total Company		Industrial		Aerospace		Total Company
Products and Services
Engineered Components Products	$	63,069	$	—	$	63,069	$	198,291	$	—	$	198,291
Molding Solutions Products	110,546		—		110,546		323,242		—		323,242
Force & Motion Control Products	45,676		—		45,676		144,746		—		144,746
Automation Products	12,397		—		12,397		41,315		—		41,315
Aerospace Original Equipment Manufacturer Products	—		92,885		92,885		—		274,708		274,708
Aerospace Aftermarket Products and Services	—		48,014		48,014		—		138,645		138,645
	$	231,688	$	140,899	$	372,587	$	707,594	$	413,353	$	1,120,947

Geographic Regions ^(A)
Americas	$	93,086	$	100,949	$	194,035	$	278,520	$	299,220	$	577,740
Europe	77,308		25,534		102,842		261,388		73,248		334,636
Asia	60,433		13,444		73,877		164,844		38,051		202,895
Rest of World	861		972		1,833		2,842		2,834		5,676
	$	231,688	$	140,899	$	372,587	$	707,594	$	413,353	$	1,120,947

(A) Sales by geographic region are based on the location to which the product is shipped.

Revenue from products and services transferred to customers at a point in time accounted for approximately 90 percent and 85 percent of total revenue for the three and nine month periods ended September 30, 2020, respectively, and approximately 90 percent of revenue for the three and nine month periods ended September 30, 2019. A majority of revenue within the Industrial segment and Aerospace OEM business, along with a portion of revenue within the Aerospace Aftermarket business, is recognized at a point in time, primarily when the product or solution is shipped to the customer.

Revenue from products and services transferred to customers over time accounted for approximately 10 percent and 15 percent of total revenue for the three and nine month periods ended September 30, 2020, respectively, and approximately 10 percent of revenue for the three and nine month periods ended September 30, 2019. The Company recognizes revenue over time in instances where a contract supports a continual transfer of control to the customer. Substantially all of our revenue in the Aerospace maintenance repair and overhaul business and a portion of the Engineered Components products, Molding Solutions products and Aerospace OEM products is recognized over time. Within the Molding Solutions and Aerospace Aftermarket businesses, this continual transfer of control to the customer results from repair and refurbishment work performed on customer-controlled assets. With other contracts, this continual transfer of control to the customer is supported by clauses in the contract where we deliver products that do not have an alternative use and require an enforceable right to payment of costs incurred (plus a reasonable profit) or the Company has a contractual right to complete any work in process and receive full contract price.

The majority of our revenues are from contracts that are for less than one year, however certain Aerospace OEM and Molding Solutions business contracts extend beyond one year. In the Industrial segment, customers are typically OEMs or suppliers to OEMs and, in some businesses, distributors. In the Aerospace segment, customers include commercial airlines, OEMs and other aircraft and military parts and service providers.

A performance obligation represents a promise within a contract to provide a distinct good or service to the customer. Revenue is recognized in an over time model based on the extent of progress towards completion of the performance obligation. The selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. The Company utilizes the cost-to-cost measure of progress for over time contracts as we believe this measure best depicts the transfer of control to the customer, which occurs as we incur costs on contracts.

Adjustments to net sales, cost of sales and the related impact to operating income are recognized as necessary in the period they become known. Revenue recognized from performance obligations satisfied in previous periods was not material in both the three and nine months ended September 30, 2020 and 2019.

Contract Balances. The timing of revenue recognition, invoicing and cash collections affect accounts receivable, unbilled receivables (contract assets) and customer advances and deposits (contract liabilities) on the Consolidated Balance Sheets.

Unbilled Receivables (Contract Assets) - Pursuant to the over time revenue recognition model, revenue may be recognized prior to the customer being invoiced. An unbilled receivable is recorded to reflect revenue that is recognized when 1) the cost-to-cost method is applied and 2) such revenue exceeds the amount invoiced to the customer. Unbilled receivables are included within prepaid expenses and other current assets on the Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019.

Customer Advances and Deposits (Contract Liabilities) - The Company may receive a customer advance or deposit, or have an unconditional right to receive a customer advance, prior to revenue being recognized. Certain contracts within the Molding Solutions business, for example, may require such advances. Since the performance obligations related to such advances may not have been satisfied, a contract liability is established. An offsetting asset of equal amount is recorded as an account receivable until the advance is collected. Advances and deposits are included within accrued liabilities on the Consolidated Balance Sheets until the respective revenue is recognized. Advance payments are not considered a significant financing component as they are generally received less than one year before the customer solution is completed. These assets and liabilities are reported on the Consolidated Balance Sheets on an individual contract basis at the end of each reporting period.

Net contract liabilities consisted of the following:


	September 30, 2020		December 31, 2019		$ Change		% Change
Unbilled receivables (contract assets)	$	36,201	$	22,444	$	13,757	61	%
Contract liabilities	(45,499)		(55,076)		9,577		(17)	%
Net contract liabilities	$	(9,298)	$	(32,632)	$	23,334	(72)	%

Contract liabilities balances at September 30, 2020 and December 31, 2019 include $12,536 and $16,971, respectively, of customer advances for which the Company has an unconditional right to collect payment. Accounts receivable, as presented on the Consolidated Balance Sheet, includes corresponding balances at September 30, 2020 and December 31, 2019, respectively.

Changes in the net contract liabilities balance during the nine-month period ended September 30, 2020 were impacted by a $9,577 decrease in contract liabilities, driven primarily by revenue recognized in the current period, partially offset by new customer advances and deposits. Adding to this net contract liability decrease was a $13,757 increase in contract assets, driven primarily by contract progress (i.e. unbilled receivable), partially offset by earlier contract progress being invoiced to the customer.

The Company recognized approximately 25% and 75% of the revenue related to the contract liability balance as of December 31, 2019 during the three and nine months ended September 30, 2020, respectively, and approximately 15% and 70% of the revenue related to the contract liability balance as of December 31, 2018 during the three and nine months ended September 30, 2019, respectively, primarily representing revenue from the sale of molds and hot runners within the Molding Solutions business.

Remaining Performance Obligations. The Company has elected to disclose remaining performance obligations only for contracts with an original duration of greater than one year. Such remaining performance obligations represent the transaction price of firm orders for which work has not yet been performed and, for Aerospace, excludes projections of components and assemblies that Aerospace OEM customers anticipate purchasing in the future under existing programs, which represent orders that are beyond lead time and do not represent performance obligations pursuant to accounting guidance. As of September 30, 2020, the aggregate amount of the transaction price allocated to remaining performance obligations was $170,388. The Company expects to recognize revenue on approximately 75% of the remaining performance obligations over the next 12 months, with the remainder being recognized within 24 months.

5. Stockholders' Equity

A schedule of consolidated changes in equity for the nine months ended September 30, 2020 is as follows (shares in thousands):


	Common Stock (Number of Shares)	Common Stock (Amount)		Additional Paid-In Capital		Treasury Stock (Number of Shares)	Treasury Stock (Amount)		Retained Earnings		Accumulated Other Non-Owner Changes to Equity		Total Stockholders’ Equity
December 31, 2019	63,873	$	639	$	489,282	13,051	$	(498,074)	$	1,489,176	$	(210,495)	$	1,270,528
Comprehensive income	—	—		—		—	—		29,733		(34,189)		(4,456)
Dividends declared ($0.16 per share)	—	—		—		—	—		(8,133)		—		(8,133)
Common stock repurchases	—	—		—		396	(15,550)		—		—		(15,550)
Employee stock plans	17	—		2,743		2	(84)		(88)		—		2,571
March 31, 2020	63,890	$	639	$	492,025	13,449	$	(513,708)	$	1,510,688	$	(244,684)	$	1,244,960
Comprehensive income	—	—		—		—	—		567		17,044		17,611
Dividends declared ($0.16 per share)	—	—		—		—	—		(8,072)		—		(8,072)

Employee stock plans	14	—		3,394		1	(53)		(134)		—		3,207
June 30, 2020	63,904	$	639	$	495,419	13,450	$	(513,761)	$	1,503,049	$	(227,640)	$	1,257,706
Comprehensive income	—	—		—		—	—		15,358		42,139		57,497
Dividends declared ($0.16 per share)	—	—		—		—	—		(8,097)		—		(8,097)

Employee stock plans	237	2		3,601		76	(3,039)		(14)		—		550
September 30, 2020	64,141	$	641	$	499,020	13,526	$	(516,800)	$	1,510,296	$	(185,501)	$	1,307,656

A schedule of consolidated changes in equity for the nine months ended September 30, 2019 is as follows (shares in thousands):


	Common Stock (Number of Shares)	Common Stock (Amount)		Additional Paid-In Capital		Treasury Stock (Number of Shares)	Treasury Stock (Amount)		Retained Earnings		Accumulated Other Non-Owner Changes to Equity		Total Stockholders’ Equity
December 31, 2018	63,367	$	634	$	470,818	12,034	$	(441,668)	$	1,363,772	$	(190,500)	$	1,203,056
Comprehensive income	—	—		—		—	—		33,992		(8,178)		25,814
Dividends declared ($0.16 per share)	—	—		—		—	—		(8,217)		—		(8,217)



Employee stock plans	51	—		4,039		1	(80)		(109)		—		3,850
March 31, 2019	63,418	$	634	$	474,857	12,035	$	(441,748)	$	1,389,438	$	(198,678)	$	1,224,503
Comprehensive income	—	—		—		—	—		37,616		4,698		42,314
Dividends declared ($0.16 per share)	—	—		—		—	—		(8,086)		—		(8,086)
Common stock repurchases	—	—		—		900	(50,347)		—		—		(50,347)
Employee stock plans	18	—		3,285		2	(106)		(178)		—		3,001
June 30, 2019	63,436	$	634	$	478,142	12,937	$	(492,201)	$	1,418,790	$	(193,980)	$	1,211,385
Comprehensive income	—	—		—		—	—		45,769		(37,345)		8,424
Dividends declared ($0.16 per share)	—	—		—		—	—		(8,111)		—		(8,111)

Employee stock plans	321	4		4,713		112	(5,727)		10		—		(1,000)
September 30, 2019	63,757	$	638	$	482,855	13,049	$	(497,928)	$	1,456,458	$	(231,325)	$	1,210,698

6. Net Income Per Common Share

For the purpose of computing diluted net income per common share, the weighted-average number of common shares outstanding is increased for the potential dilutive effects of stock-based incentive plans. For the purpose of computing diluted net income per common share, the weighted-average number of common shares outstanding was increased by 103,936 and 304,324 for the three-month periods ended September 30, 2020 and 2019, respectively, and by 236,930 and 441,773 for the nine-month periods ended September 30, 2020 and 2019, respectively, to account for the potential dilutive effect of stock-based incentive plans. There were no adjustments to net income for the purposes of computing income available to common stockholders for the periods.

The calculation of weighted-average diluted shares outstanding excludes all shares that would have been anti-dilutive. During the three-month periods ended September 30, 2020 and 2019, the Company excluded 525,738 and 257,979 stock awards, respectively, from the calculation of weighted-average diluted shares outstanding as the stock awards were considered anti-dilutive. During the nine-month periods ended September 30, 2020 and 2019, the Company excluded 488,401 and 295,043 stock awards, respectively, from the calculation of weighted-average diluted shares outstanding as the stock awards were considered anti-dilutive.

The Company granted 102,500 stock options, 79,994 restricted stock unit awards and 81,283 performance share awards ("PSAs") in February 2020 as part of its annual long-term incentive equity grant awards. All of the stock options and the restricted stock unit awards vest upon meeting certain service conditions. The restricted stock unit awards are included in basic weighted-average common shares outstanding as they contain nonforfeitable rights to dividend payments. The PSAs are part of the long-term Performance Share Award Program and are based on performance goals that are driven by a combination of independently measured metrics (depending on the grant year) with each metric being weighted equally. The metrics for awards granted in 2020 include the Company’s total shareholder return (“TSR”), return on invested capital (“ROIC”) and operating income before depreciation and amortization growth ("EBITDA growth"). The TSR and EBITDA growth metrics are designed to assess the long-term Company performance relative to the performance of companies included in the Russell 2000 Index over a three-year performance period. ROIC is designed to assess the Company's performance compared to pre-established Company targets over a three-year performance period. The participants can earn from zero to 250% of the target award and the award includes a forfeitable right to dividend equivalents, which are not included in the aggregate target award numbers. The fair value of the TSR is determined using a Monte Carlo valuation method as the award contains a market condition.

7. Inventories

The components of inventories consisted of:


	September 30, 2020		December 31, 2019
Finished goods	$	82,175	$	69,594
Work-in-process	84,310		88,196
Raw material and supplies	79,483		74,916
	$	245,968	$	232,706

8. Goodwill and Other Intangible Assets

Goodwill:

The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company as of and for the period ended September 30, 2020:


	Industrial		Aerospace		Total Company
December 31, 2019	$	902,236	$	30,786	$	933,022




Foreign currency translation	36,233		—		36,233
September 30, 2020	$	938,469	$	30,786	$	969,255

In the second quarter of 2020, management performed its annual impairment testing of goodwill and determined that there was no goodwill impairment.

Other Intangible Assets:

Other intangible assets consisted of:


		September 30, 2020						December 31, 2019
	Range of Life -Years	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
Amortized intangible assets:
Revenue Sharing Programs (RSPs)	Up to 30	$	299,500	$	(141,821)	$	299,500	$	(135,466)
Component Repair Programs (CRPs)	Up to 30	111,839		(30,097)		111,839		(27,270)
Customer relationships	10-16	338,366		(113,662)		338,366		(98,953)
Patents and technology	4-11	123,433		(75,006)		123,433		(68,188)
Trademarks/trade names	10-30	10,949		(10,323)		10,949		(10,145)
Other	Up to 15	10,746		(4,449)		10,746		(4,014)
		894,833		(375,358)		894,833		(344,036)
Unamortized intangible assets:
Trade names		55,670		—		55,670		—
Foreign currency translation		(14,679)		—		(25,351)		—
Other intangible assets		$	935,824	$	(375,358)	$	925,152	$	(344,036)

Estimated amortization of intangible assets for future periods is as follows: 2020 (remainder) - $9,000; 2021 - $42,000; 2022- $41,000; 2023 - $41,000, 2024 - $40,000 and 2025- $39,000.

In the second quarter of 2020, management performed its annual impairment testing of its trade names, which represent indefinite-lived intangible assets. Based on this assessment, there were no impairments.

9. Debt

Long-term debt and notes and overdrafts payable at September 30, 2020 and December 31, 2019 consisted of:


	September 30, 2020						December 31, 2019
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Revolving credit agreement	$	597,102	$	602,054	$	720,379	$	737,816
3.97% Senior Notes	100,000		110,656		100,000		104,151
Borrowings under lines of credit and overdrafts	14,490		14,490		7,724		7,724
Finance leases	5,842		5,998		6,266		6,515
Other foreign bank borrowings	289		289		406		410
	717,723		733,487		834,775		856,616
Less current maturities	(16,310)				(9,758)
Long-term debt	$	701,413			$	825,017

2018, thereby increased the borrowing availability of the existing facility to $1,000,000. The Company may also request access to the residual $200,000 of the accordion feature. Depending on the Company’s consolidated leverage ratio, and at the election of the Company, borrowings under the Amended Credit Agreement will bear interest at either LIBOR plus a margin of between 1.10% and 1.70% or the base rate, as defined in the Amended Credit Agreement, plus a margin of 0.10% to 0.70%. Multi-currency borrowings, pursuant to the Amended Credit Agreement, bear interest at their respective interbank offered rate (i.e. Euribor) or 0.00% (higher of the two rates) plus a margin of between 1.10% and 1.70%.

Borrowings and availability under the Amended Credit Agreement were $597,102 and $402,898, respectively, at September 30, 2020 and $720,379 and $279,621, respectively, at December 31, 2019, subject to covenants in the Company's revolving debt agreements. The borrowing capacity under the Amended Credit Agreement was limited by the Senior Debt Ratio (defined below) to $126,285 as of September 30, 2020. The average interest rate on these borrowings was 1.22% and 1.76% on September 30, 2020 and December 31, 2019, respectively. Borrowings included Euro-denominated borrowings of 359,450 Euros ($422,102) at September 30, 2020 and 504,690 Euros ($565,379) at December 31, 2019. The fair value of the borrowings is based on observable Level 2 inputs. The borrowings were valued using discounted cash flows based upon the Company's estimated interest costs for similar types of borrowings. In 2019, the Company borrowed 44,100 Euros ($49,506) under the Amended Credit Facility through an international subsidiary. The proceeds were distributed to the parent company and subsequently used to pay down U.S. borrowings under the Amended Credit Agreement.

The 3.97% Senior Notes are senior unsecured obligations of the Company and pay interest semi-annually on April 17 and October 17 of each year at an annual rate of 3.97%. The 3.97% Senior Notes will mature on October 17, 2024 unless earlier prepaid in accordance with their terms. Subject to certain conditions, the Company may, at its option, prepay all or any part of the 3.97% Senior Notes in an amount equal to 100% of the principal amount of the 3.97% Senior Notes so prepaid, plus any accrued and unpaid interest to the date of prepayment, plus the Make-Whole Amount, as defined in the Note Purchase Agreement, with respect to such principal amount being prepaid. The fair value of the 3.97% Senior Notes was determined using the U.S. Treasury yield and a long-term credit spread for similar types of borrowings, which represent Level 2 observable inputs.

The Company's borrowing capacity remains limited by various debt covenants in the Amended Credit Agreement and the Note Purchase Agreement (the "Agreements"). The Agreements require the Company to maintain a ratio of Consolidated Senior Debt, as defined, to Consolidated EBITDA, as defined, of not more than 3.25 times ("Senior Debt Ratio"), a ratio of Consolidated Total Debt, as defined, to Consolidated EBITDA of not more than 3.75 times ("Total Debt Ratio") and a ratio of Consolidated EBITDA to Consolidated Cash Interest Expense, as defined, of not less than 4.25, in each case at the end of each fiscal quarter; provided that the debt to EBITDA ratios are permitted to increase for a period of four fiscal quarters after the closing of certain permitted acquisitions. A permitted acquisition is defined as an acquisition exceeding $150,000, for which the acquisition of Gimatic on October 31, 2018 qualified. With the completion of a permitted acquisition, the Senior Debt Ratio cannot exceed 3.50 times and the Total Debt Ratio cannot exceed 4.25 times. The increased ratios were allowed for a period of four fiscal quarters subsequent to the close of the permitted acquisition and therefore expired in the fourth quarter of 2019.

On October 8, 2020, the Company entered into the sixth amendment to the Amended Credit Agreement with Bank of America (the “Sixth Amendment”) and the first amendment to the Note Purchase Agreement with New York Life (the “First NPA Amendment”). The Sixth Amendment and the First NPA Amendment provided for an increase in the Company’s maximum ratio of Consolidated Senior Debt, as defined, to Consolidated EBITDA, as defined, from 3.25 times (or, if a certain permitted acquisition above $150,000 is consummated, 3.50 times) to 3.75 times in each case at the end of the four fiscal quarters, beginning with December 31, 2020. Additionally, the Sixth Amendment requires the Company to maintain a maximum ratio of Consolidated Total Debt, as defined, to Consolidated EBITDA, of not more than 3.75 times in each case, at the end of the four fiscal quarters, beginning with December 31, 2020 and regardless of whether a permitted acquisition, as defined, is consummated. Furthermore, the First NPA Amendment provides for (i) adjustments to the ratio of Consolidated Total Debt, as defined, to Consolidated EBITDA, as defined, to conform to a more restrictive total leverage ratio that may be required under the Amended Credit Agreement, (ii) an increase in the amount of allowable add-back for restructuring charges when calculating Consolidated EBITDA from $15,000 to $25,000 and (iii) a required fee payment equal to 0.50% per annum times the daily outstanding principal amount of the note during each of the four fiscal quarters, following the quarter ended December 31, 2020, if the Company’s Senior Leverage Ratio, as defined, exceeds 3.25 times. In October 2020, the Company paid fees and expenses of $1,384 in conjunction with executing the Amendments; such fees will be deferred within Other Assets on the accompanying Consolidated Balance Sheet and amortized into interest expense on the Consolidated Statements of Income

through their expiration. The increased ratios related to the close of a permitted acquisition have been suspended during the four fiscal quarters in which the Amendments are in effect. At September 30, 2020, the Company was in compliance with all covenants under the Agreements. The Company currently anticipates that it will maintain compliance with all of its covenants in the next four quarters while continuing to monitor its future compliance based on current and future economic conditions.

In addition, the Company has approximately $82,000 in uncommitted short-term bank credit lines ("Credit Lines") and overdraft facilities. The Credit Lines are accessed locally and are available primarily within the U.S., Europe and Asia. The Credit Lines are subject to the applicable borrowing rates within each respective country and vary between jurisdictions (i.e. LIBOR, Euribor, etc.). Under the Credit Lines, $14,300 was borrowed at September 30, 2020 at an average interest rate of 1.10% and $7,700 was borrowed at December 31, 2019 at an average interest rate of 2.38%. The Company had also borrowed $190 and $24 under the overdraft facilities at September 30, 2020 and December 31, 2019, respectively. Repayments under the Credit Lines are due within one month after being borrowed. Repayments of the overdrafts are generally due within two days after being borrowed. The carrying amounts of the Credit Lines and overdrafts approximate fair value due to the short maturities of these financial instruments.

The Company also has several finance leases under which $5,842 and $6,266 was outstanding at September 30, 2020 and December 31, 2019, respectively. The fair value of the finance leases are based on observable Level 2 inputs. These instruments were valued using discounted cash flows based upon the Company's estimated interest costs for similar types of borrowings.

At September 30, 2020 and December 31, 2019, the Company also had other foreign bank borrowings of $289 and $406, respectively. The fair value of the other foreign bank borrowings was based on observable Level 2 inputs. These instruments were valued using discounted cash flows based upon the Company's estimated interest costs for similar types of borrowings.

10. Derivatives

The Company has manufacturing and sales facilities around the world and thus makes investments and conducts business transactions denominated in various currencies. The Company is also exposed to fluctuations in interest rates and commodity price changes. These financial exposures are monitored and managed by the Company as an integral part of its risk management program.

Financial instruments have been used by the Company to hedge its exposure to fluctuations in interest rates. The Company entered into an interest rate swap agreement (the "Swap") on April 28, 2017, with one bank, which converts the interest on the first $100,000 of the Company's one-month LIBOR-based borrowings from a variable rate plus the borrowing spread to a fixed rate of 1.92% plus the borrowing spread. The Swap expires on January 31, 2022 and is accounted for as a cash flow hedge.

The Company also uses financial instruments to hedge its exposures to fluctuations in foreign currency exchange rates. The Company has various contracts outstanding which primarily hedge recognized assets or liabilities and anticipated transactions in various currencies including the Euro, British pound sterling, U.S. dollar, Canadian dollar, Japanese yen, Singapore dollar, Korean won, Swedish kroner, Chinese renminbi, Mexican peso, Hong Kong dollar and Swiss franc. Certain foreign currency derivative instruments are treated as cash flow hedges of forecasted transactions. All foreign exchange contracts are due within two years.

The Company does not use derivatives for speculative or trading purposes or to manage commodity exposures. Changes in the fair market value of derivatives that qualify as cash flow hedges are recorded to accumulated other non-owner changes to equity. Amounts recorded to accumulated other non-owner changes to equity are reclassified to earnings in a manner that matches the earnings impact of the hedged transaction. Amounts related to contracts that are not designated as hedges are recorded directly to earnings.

The Company's policy for classifying cash flows from derivatives is to report the cash flows consistent with the underlying hedged item. Other financing cash flows during the first nine months of 2020 and 2019, as presented on the Consolidated Statements of Cash Flows, include $1,880 and $12,593, respectively, of net cash payments related to the settlement of foreign currency hedges related to intercompany financing.

The following table sets forth the fair value amounts of derivative instruments held by the Company:


	Derivative Assets								Derivative Liabilities
		Fair Value							Fair Value
	Balance Sheet Location	September 30, 2020		December 31, 2019		Balance Sheet Location	September 30, 2020		December 31, 2019
Derivatives designated as hedging instruments:
Interest rate contracts	Other assets	$	—	$	—	Other liabilities	$	(2,425)	$	(820)
Foreign exchange contracts	Prepaid expenses and other current assets	235		700		Accrued liabilities	—		—
Total derivatives designated as hedging instruments		235		700			(2,425)		(820)

Derivatives not designated as hedging instruments:
Foreign exchange contracts	Prepaid expenses and other current assets	405		1,375		Accrued liabilities	(221)		(1)
Total derivatives not designated as hedging instruments		405		1,375			(221)		(1)

Total derivatives		$	640	$	2,075		$	(2,646)	$	(821)

The following table sets forth the effect of hedge accounting on accumulated other comprehensive (loss) income for the three and nine-month periods ended September 30, 2020 and 2019:


	Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Income (Loss) on Derivative															Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income
	Three Months Ended September 30,						Nine Months Ended September 30,							Three Months Ended September 30,						Nine Months Ended September 30,
Derivatives in Hedging Relationships	2020		2019		2020		2019			2020		2019		2020					2019
Derivatives in Cash Flow Hedging Relationships:
Interest rate contracts	$	344	$	(178)	$	(1,223)	$	(1,846)	Interest expense	$	(449)	$	86	$	(866)		$	367
Foreign exchange contracts	(265)		10		(224)		(114)		Net sales	237		(199)		(213)			(788)
Total	$	79	$	(168)	$	(1,447)	$	(1,960)		$	(212)	$	(113)	$	(1,079)		$	(421)

The following table sets forth the effect of hedge accounting on the Consolidated Statements of Income for the three-month periods ended September 30, 2020 and 2019:


	Location and Amount of Gain (Loss) Recognized in Income on Hedging Relationships
	Three Months Ended September 30,
	2020						2019
	Net sales		Interest expense		Net sales		Interest expense
Total amounts of income and expense line items presented in the consolidated statements of income in which the effects of hedges are recorded	$	269,059	$	3,701	$	372,587	$	5,344
The effects of hedging:
Gain (Loss) on cash flow hedging relationships
Interest rate contracts
Amount of gain (loss) reclassified from accumulated other comprehensive income (loss) into income			(449)				86
Foreign exchange contracts
Amount of gain (loss) reclassified from accumulated other comprehensive income (loss) into income	237				(199)

The following table sets forth the effect of hedge accounting on the consolidated statements of income for the nine-month periods ended September 30, 2020 and 2019:


	Location and Amount of Gain (Loss) Recognized in Income on Hedging Relationships
	Nine Months Ended September 30,
	2020						2019
	Net sales		Interest expense		Net sales		Interest expense
Total amounts of income and expense line items presented in the consolidated statements of income in which the effects of hedges are recorded	$	835,266	$	11,924	$	1,120,947	$	15,856
The effects of hedging:
Gain (Loss) on cash flow hedging relationships
Interest rate contracts
Amount of (loss) gain reclassified from accumulated other comprehensive income (loss) into income			(866)				367
Foreign exchange contracts
Amount of (loss) gain reclassified from accumulated other comprehensive income (loss) into income	(213)				(788)

The following table sets forth the effect of derivatives not designated as hedging instruments on the consolidated statements of income for the three and nine-month periods ended September 30, 2020 and 2019:


	Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivative^(A)
				Three Months Ended September 30,									Nine Months Ended September 30,
Derivatives Not Designated as Hedging Instruments				2020			2019			2020			2019
Foreign exchange contracts	Other expense (income), net	$	3,079		$	(11,662)		$	(2,743)		$	(15,182)

(A) Such amounts were substantially offset by the net (gain) loss recorded on the underlying hedged asset or liability, also recorded in other expense (income), net.

11. Fair Value Measurements

The provisions of the accounting standard for fair value define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. This standard classifies the inputs used to measure fair value into the following hierarchy:

Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2 Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.

Level 3 Unobservable inputs for the asset or liability.

The following table provides the assets and liabilities reported at fair value and measured on a recurring basis:


			Fair Value Measurements Using
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
September 30, 2020
Asset derivatives	$	640	$	—	$	640	$	—
Liability derivatives	(2,646)		—		(2,646)		—
Bank acceptances	13,427		—		13,427		—
Rabbi trust assets	2,889		2,889		—		—
Total	$	14,310	$	2,889	$	11,421	$	—

December 31, 2019
Asset derivatives	$	2,075	$	—	$	2,075	$	—
Liability derivatives	(821)		—		(821)		—
Bank acceptances	14,460		—		14,460		—
Rabbi trust assets	2,947		2,947		—		—
Total	$	18,661	$	2,947	$	15,714	$	—

The derivative contracts are valued using observable current market information as of the reporting date such as the prevailing LIBOR-based interest rates and foreign currency spot and forward rates. Bank acceptances represent financial instruments accepted from certain China-based customers in lieu of cash paid on receivables, generally range from three to six months in maturity and are guaranteed by banks. The carrying amounts of the bank acceptances, which are included within prepaid expenses and other current assets, approximate fair value due to their short maturities. The fair values of rabbi trust assets are based on quoted market prices from various financial exchanges.

12. Pension and Other Postretirement Benefits

Pension and other postretirement benefits expenses consisted of the following:


	Three Months Ended September 30,						Nine Months Ended September 30,
Pensions	2020		2019		2020		2019
Service cost	$	1,620	$	1,356	$	4,704	$	4,064
Interest cost	3,815		4,539		11,438		13,647
Expected return on plan assets	(7,594)		(7,389)		(22,391)		(21,816)
Amortization of prior service cost	128		101		281		302
Amortization of actuarial losses	3,502		2,215		10,148		6,658
Curtailment loss	—		—		484		—
Settlement loss	—		93		—		340

Net periodic benefit cost	$	1,471	$	915	$	4,664	$	3,195


	Three Months Ended September 30,						Nine Months Ended September 30,
Other Postretirement Benefits	2020		2019		2020		2019
Service cost	$	20	$	18	$	61	$	53
Interest cost	259		335		780		1,008
Amortization of prior service cost	6		6		20		19
Amortization of actuarial losses	9		3		27		10

Net periodic benefit cost	$	294	$	362	$	888	$	1,090

The service cost component of net periodic benefit cost is included within cost of sales and selling and administrative expenses. The components of net periodic benefit cost other than the service cost component are included in Other Income (Expense) on the Consolidated Statements of Income. The curtailment loss of $484 relates to the restructuring actions that were taken during the second quarter of 2020. See Note 17.

13. Income Taxes

The Company's effective tax rate for the first nine months of 2020 was 40.0% compared with 23.4% in the first nine months of 2019 and 23.4% for the full year 2019. The increase in the first nine months of 2020 effective tax rate from the full year 2019 rate is primarily due to a decrease in projected earnings in jurisdictions with lower rates, the recognition of tax expense related to the completed sale of the Seeger business during the first quarter of 2020, the impact of the global intangible low-taxed income tax on foreign earnings in the U.S. (despite lower U.S. income) and excess tax charges related to stock awards. The impact of these items was partially offset by a benefit related to a refund of withholding taxes that were previously paid and included in tax expense in prior years and a reduction of the statutory tax rate at one of our international operations, both of which were recognized in the first quarter of 2020.

The Aerospace and Industrial segments have a number of multi-year tax holidays in Singapore and China. These holidays are subject to the Company meeting certain commitments in the respective jurisdictions. Aerospace was granted a multi-year income tax holiday for operations recently established in Malaysia. The Company expected the holiday to begin in the third quarter of 2020, however, due to the impact of COVID-19, the start date of the holiday has been delayed. Discussions are currently being held regarding the effective start date of the holiday, with a likelihood that the holiday will be deferred until 2022. Once the start date is established, the holiday is scheduled to remain effective for ten years. The Industrial Segment has a holiday in China, for which it currently receives benefit, that is scheduled to expire at the end of 2020. The Company plans to re-apply for the holiday, but does not expect notification of potential approval until the latter half of 2021.

14. Changes in Accumulated Other Comprehensive Income (Loss) by Component

The following tables set forth the changes in accumulated other comprehensive income (loss), net of tax, by component for the nine-month periods ended September 30, 2020 and 2019:


	Gains and Losses on Cash Flow Hedges		Pension and Other Postretirement Benefit Items		Foreign Currency Items		Total
January 1, 2020	$	(115)	$	(144,047)	$	(66,333)	$	(210,495)
Other comprehensive (loss) income before reclassifications	(2,305)		(5,733)		23,774		15,736
Amounts reclassified from accumulated other comprehensive income to the consolidated statements of income	858		8,400		—		9,258
Net current-period other comprehensive (loss) income	(1,447)		2,667		23,774		24,994
September 30, 2020	$	(1,562)	$	(141,380)	$	(42,559)	$	(185,501)


	Gains and Losses on Cash Flow Hedges		Pension and Other Postretirement Benefit Items		Foreign Currency Items		Total
January 1, 2019	$	834	$	(138,690)	$	(52,644)	$	(190,500)
Other comprehensive loss before reclassifications	(2,300)		(18)		(44,513)		(46,831)
Amounts reclassified from accumulated other comprehensive income to the consolidated statements of income	340		5,666		—		6,006
Net current-period other comprehensive (loss) income	(1,960)		5,648		(44,513)		(40,825)

September 30, 2019	$	(1,126)	$	(133,042)	$	(97,157)	$	(231,325)

The following table sets forth the reclassifications out of accumulated other comprehensive income (loss) by component for the three-month periods ended September 30, 2020 and 2019:


Details about Accumulated Other Comprehensive Income (Loss) Components	Amount Reclassified from Accumulated Other Comprehensive Income (Loss)					Affected Line Item in the Consolidated Statements of Income
	Three Months Ended September 30, 2020		Three Months Ended September 30, 2019
Gains and losses on cash flow hedges
Interest rate contracts	$	(449)	$	86	Interest expense
Foreign exchange contracts	237		(199)		Net sales
	(212)		(113)		Total before tax
	85		19		Tax benefit
	(127)		(94)		Net of tax

Pension and other postretirement benefit items
Amortization of prior service costs	$	(134)	$	(107)	(A)
Amortization of actuarial losses	(3,511)		(2,218)		(A)

Settlement loss	—		(93)		(A)
	(3,645)		(2,418)		Total before tax
	844		554		Tax benefit
	(2,801)		(1,864)		Net of tax

Total reclassifications in the period	$	(2,928)	$	(1,958)

The following table sets forth the reclassifications out of accumulated other comprehensive income (loss) by component for the nine month periods ended September 30, 2020 and 2019:


Details about Accumulated Other Comprehensive Income (Loss) Components	Amount Reclassified from Accumulated Other Comprehensive Income (Loss)					Affected Line Item in the Consolidated Statements of Income
	Nine Months Ended September 30, 2020		Nine Months Ended September 30, 2019
Gains and losses on cash flow hedges
Interest rate contracts	$	(866)	$	367	Interest expense
Foreign exchange contracts	(213)		(788)		Net sales
	(1,079)		(421)		Total before tax
	221		81		Tax benefit
	(858)		(340)		Net of tax

Pension and other postretirement benefit items
Amortization of prior service costs	$	(301)	$	(321)	(A)
Amortization of actuarial losses	(10,175)		(6,668)		(A)
Curtailment loss	(484)		—		(A)
Settlement loss	—		(340)		(A)
	(10,960)		(7,329)		Total before tax
	2,560		1,663		Tax benefit
	(8,400)		(5,666)		Net of tax

Total reclassifications in the period	$	(9,258)	$	(6,006)

(A) These accumulated other comprehensive income (loss) components are included within the computation of net periodic Pension and Other Postretirement Benefits cost. See Note 12.

15. Information on Business Segments

The Company is organized based upon the nature of its products and services and reports under two global business segments: Industrial and Aerospace. Segment information is consistent with how management reviews the businesses, makes investing and resource allocation decisions and assesses operating performance. The Company has not aggregated operating segments for purposes of identifying these two reportable segments.

Industrial is a global provider of highly-engineered, high-quality precision components, products and systems for critical applications serving a diverse customer base in end-markets such as transportation, industrial equipment, automation, personal care, packaging, electronics, and medical devices. Focused on innovative custom solutions, Industrial participates in the design phase of components and assemblies whereby customers receive the benefits of application and systems engineering, new product development, testing and evaluation, and the manufacturing of final products. Products are sold primarily through its direct sales force and global distribution channels. Industrial's Molding Solutions business designs and manufactures customized hot runner systems, advanced mold cavity sensors and process control systems, and precision high cavitation mold assemblies - collectively, the enabling technologies for many complex injection molding applications. The Force & Motion Control business provides innovative cost effective force and motion control solutions for a wide range of metal forming and other industrial markets. The Automation business designs and develops robotic grippers, advanced end-of-arm tooling systems, sensors and other automation components for intelligent robotic handling solutions and industrial automation applications. Industrial's Engineered Components business manufactures and supplies precision mechanical products used in transportation and industrial applications, including mechanical springs, and high-precision punched and fine-blanked components.

Aerospace's original equipment manufacturing ("OEM") business is a global manufacturer of complex fabricated and precision-machined components and assemblies for turbine engines, nacelles and structures for both commercial and military aircraft. The

Aerospace aftermarket business provides aircraft engine component MRO services, including services performed under our Component Repair Programs (“CRPs”), for many of the world’s major turbine engine manufacturers, commercial airlines and the military. The Aerospace aftermarket activities also include the manufacture and delivery of aerospace aftermarket spare parts, including Revenue Sharing Programs (“RSPs”) under which the Company receives an exclusive right to supply designated aftermarket parts over the life of specific aircraft engine programs.

The following tables set forth information about the Company's operations by its two reportable segments:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		2020		2019
Net sales
Industrial	$	196,916	$	231,688	$	561,047	$	707,594
Aerospace	72,148		140,899		274,227		413,353
Intersegment sales	(5)		—		(8)		—
Total net sales	$	269,059	$	372,587	$	835,266	$	1,120,947

Operating profit
Industrial	$	24,438	$	34,836	$	42,063	$	83,785
Aerospace	6,805		32,749		48,609		91,407
Total operating profit	31,243		67,585		90,672		175,192
Interest expense	3,701		5,344		11,924		15,856
Other expense (income), net	47		2,524		2,700		6,043
Income before income taxes	$	27,495	$	59,717	$	76,048	$	153,293


	September 30, 2020		December 31, 2019
Assets
Industrial	$	1,834,736	$	1,879,258
Aerospace	631,765		704,318
Other ^(A)	143,615		154,759
Total assets	$	2,610,116	$	2,738,335

(A) "Other" assets include corporate-controlled assets, the majority of which are cash and cash equivalents and deferred tax assets.

16. Commitments and Contingencies

Product Warranties

The Company provides product warranties in connection with the sale of certain products. From time to time, the Company is subject to customer claims with respect to product warranties. The Company accrues its estimated exposure for warranty claims at the time of sale based upon the length of the warranty period, historical experience and other related information known to the Company. Liabilities related to product warranties and extended warranties were not material as of September 30, 2020 and December 31, 2019.

Litigation

The Company is subject to litigation from time to time in the ordinary course of business and various other suits, proceedings and claims are pending involving the Company and its subsidiaries. The Company records a loss contingency liability when a loss is considered probable and the amount can be reasonably estimated. While it is not possible to determine the ultimate disposition of each of these proceedings and whether they will be resolved consistent with the Company's beliefs, the Company expects that the outcome of such proceedings, individually or in the aggregate, will not have a material adverse effect on financial condition or results of operations.

17. Business Reorganization

In June 2020, the Company announced restructuring and workforce reduction actions ("actions") to be implemented across its businesses and functions in response to the macroeconomic disruption in global industrial and aerospace end markets arising from COVID-19. A resulting pre-tax charge of $18,493 was recorded through the third quarter of 2020, primarily related to employee severance and other termination benefits, with the amounts expected to be paid by the end of 2021. These actions are expected to be substantially completed in 2020 and reduce the Company’s global workforce by approximately 8%. A corresponding liability of $15,119, per below, was included within accrued liabilities as of September 30, 2020. The Company expects to incur additional costs of approximately $2,000 through the first half of 2021 related to these actions. The employee termination costs are recorded primarily within Selling and Administrative Expenses in the accompanying Consolidated Statements of Income. Of the aggregate charges recorded, $2,243 is reflected within the results of the Aerospace segment, $15,766 is reflected within the results of the Industrial segment and $484, a pension curtailment loss, is included in Other expense (income), net.

The following table sets forth the change in the liability related to these actions:


December 31, 2019	$	—
Employee severance and other termination benefits	17,614
Payments	(2,495)
September 30, 2020	$	15,119

_________________________________________________________________________________________

With respect to the unaudited consolidated financial information of Barnes Group Inc. for the three months period ended September 30, 2020 and 2019, PricewaterhouseCoopers LLP reported that they have applied limited procedures in accordance with professional standards for a review of such information. However, their separate report dated October 26, 2020 appearing herein, states that they did not audit and they do not express an opinion on that unaudited consolidated financial information. Accordingly, the degree of reliance on their report should be restricted in light of the limited nature of the review procedures applied. PricewaterhouseCoopers LLP is not subject to the liability provisions of Section 11 of the Securities Act of 1933, as amended, for their report on the unaudited consolidated financial information because that report is not a “report” or a “part” of the registration statement prepared or certified by PricewaterhouseCoopers LLP within the meaning of Sections 7 and 11 of the Securities Act of 1933, as amended.

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Barnes Group Inc.

Results of Review of Interim Financial Information

We have reviewed the accompanying consolidated balance sheet of Barnes Group Inc. and its subsidiaries (the “Company”) as of September 30, 2020, and the related consolidated statements of income and of comprehensive income for the three-month and nine-month periods ended September 30, 2020 and 2019 and the consolidated statement of cash flows for the nine-month periods ended September 30, 2020 and 2019, including the related notes (collectively referred to as the “interim financial information”). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim financial information for it to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of the Company as of December 31, 2019, and the related consolidated statements of income, of comprehensive income, of changes in stockholders’ equity, and of cash flows for the year then ended (not presented herein), and in our report dated February 24, 2020, which included a paragraph describing a change in the manner of accounting for leases in the 2019 financial statements and revenue in the 2018 financial statements, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet information as of December 31, 2019, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

Basis for Review Results

This interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.


/s/ PricewaterhouseCoopers LLP
Hartford, Connecticut
October 26, 2020

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

OVERVIEW

Please refer to the Overview in the Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. The Annual Report on Form 10-K and other documents related to the Company are located on the Company's website: www.bginc.com.

Third Quarter Highlights

Impact of Coronavirus

In December 2019, an outbreak of a novel strain of coronavirus (“COVID-19”) began in Wuhan, China, and was subsequently declared a pandemic by the World Health Organization. The outbreak and a continued spread of the global COVID-19 pandemic has resulted in a substantial curtailment of business activities worldwide and has caused weakened economic conditions, both in the United States and abroad. As part of growing efforts to contain the spread of COVID-19 earlier in the year, a number of state, local and foreign governments imposed various restrictions on the conduct of business and travel. Certain of these restrictions remained in place throughout the third quarter. The Company's global manufacturing operations continued throughout the current quarter, however COVID-19 clearly continues to have an impact on order rates and recovery expectations within Industrial, and on a more targeted basis, Aerospace end-markets. See further discussion within “Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations - Outlooks”. As a result of COVID-19 and in support of continuing its manufacturing efforts, the Company has undertaken a number of steps to protect its employees, suppliers and customers, as their safety and well-being is priority. The Company has instituted additional precautions to comply with health and safety guidelines and to protect its employees, including enhanced deep cleaning, staggered shifts, temperature checking, use of face masks, practicing social distancing and limiting non-employees at our locations, amongst other safety related policies and procedures. Many of the Company's office workers in our manufacturing facilities, as well as the Corporate and segment headquarters, continue to work remotely, where possible. The senior management team meets regularly to review and assess the status of the Company's operations and the health and safety of its employees. The Company’s global supply chain management team continues to monitor and manage its ability to operate effectively and, to date, the Company has not experienced any significant disruptions within its supply chain. Ongoing communications with the Company's suppliers to identify and mitigate risk and to manage inventory levels will continue. Notwithstanding the Company's continued operations, COVID-19 has clearly had and may have further negative impacts on its operations, customers and supply chain despite the preventative and precautionary measures being taken.

The Company currently maintains sufficient liquidity and will continue to evaluate ways to enhance its liquidity position as it navigates through the disrupted business environment that has resulted from COVID-19. At September 30, 2020, the Company held $77.5 million in cash and cash equivalents and had $402.9 million of undrawn borrowing capacity under its $1,000.0 million Amended Credit Facility, subject to covenants in the Company's revolving debt agreements (limited by the covenants to $126.3 million as of September 30, 2020). The Company has executed amendments to its Amended Credit Agreement and its Note Purchase Agreement (defined below) in October 2020. The Company remained in compliance with all covenants under its revolving Credit Agreement, which matures in February 2022, as of September 30, 2020, and anticipates continued compliance in each of the next four quarters. See additional discussion regarding the Company's debt agreements and liquidity within “Item 2 - Liquidity and Capital Resources." At this time, the Company has not drawn on its debt agreements as it believes the availability of those funds are not at risk given the strength of the underlying bank syndicate. The Company does not currently anticipate requiring any additional debt facilities. Given the current environment, the Company is closely monitoring its cash generation, usage and preservation including the management of working capital to generate cash. To better align costs with the current business environment, the Company has taken several actions, which include restructuring and workforce reductions

(the "Actions"). Resulting pre-tax charges of $18.5 million were recorded in 2020. See additional discussion regarding the Actions within "Item 2 - Results of Operations." Additional cost savings initiatives include temporary reductions in compensation for salaried employees including Company officers and members of the Board of Directors, employee furloughs and reductions in discretionary expenses. The Actions and cost savings initiatives have allowed the Company to partially offset the operating profit impacts of lower sales volumes in the third quarter. The Actions were designed to benefit current and prospective periods, and these benefits are already being realized. In addition, management has suspended share repurchase activity.

Entering 2020, automotive, tool and die, and personal care and packaging end markets were experiencing lingering softness. Given the onset of COVID-19, sales pressure increased significantly further within these markets, although certain end-markets within Industrial have begun to show gradual signs of recovery in the third quarter of 2020. Medical end markets in which the Company participates are expected to remain favorable. Aerospace end markets were strong entering 2020, however sales for the segment declined nearly 50% in each of the second and third quarters of 2020 as compared with prior year periods. The Company anticipates continued sales pressure within OEM as certain aircraft programs have been delayed as a result of COVID-19. Within the aftermarket businesses, aircraft are being removed from service and utilization is reduced, impacting the more profitable repair and overhaul and spare parts businesses. See additional discussion regarding the anticipated financial impact of COVID-19 within “Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations - Outlooks”.

RESULTS OF OPERATIONS

Net Sales


	Three Months Ended September 30,														Nine Months Ended September 30,
(in millions)	2020		2019		Change						2020		2019		Change
Industrial	$	196.9	$	231.7	$	(34.8)	(15.0)	%	$	561.0	$	707.6	$	(146.5)	(20.7)	%
Aerospace	72.1		140.9		(68.8)		(48.8)	%	274.2		413.4		(139.1)		(33.7)	%

Total	$	269.1	$	372.6	$	(103.5)	(27.8)	%	$	835.3	$	1,120.9	$	(285.7)	(25.5)	%

COVID-19 began to impact sales during the first quarter of 2020. Beginning late in the first quarter, Industrial and Aerospace business units began to experience the negative impact on demand for certain products and services due to COVID-19's disruption of global manufacturing and consumer spending. The Company's global manufacturing, in certain regions, operated at reduced levels during the first quarter. As described further below, the impacts of COVID-19 significantly increased during the second quarter of 2020, however both segments reflected sequential sales improvements in the third quarter of 2020. Customer orders and corresponding demand for certain product remains soft, impacting comparable prior year sales volumes accordingly. The current situation remains dynamic, and therefore visibility of future operations remains challenged.

The Company reported net sales of $269.1 million in the third quarter of 2020, a decrease of $103.5 million or 27.8%, from the third quarter of 2019. Organic sales decreased by $96.7 million, or 26.0%, including decreases of $27.9 million at Industrial and $68.8 million at Aerospace. Sales at Industrial and Aerospace reflected sequential improvements of 19.3% and 2.3%, respectively, in the third quarter of 2020, as compared with the second quarter of 2020. The year-over-year decrease at Industrial was driven by organic sales declines across the Industrial business units, driven primarily by the impact of COVID-19. The Automation business experienced slight growth in organic sales as compared with the prior period. Automotive end markets remained soft relative to the prior year period, reflecting the impacts of both COVID-19 and broader global economic uncertainty, however global automotive production improved compared to the second quarter of 2020. Potential changes in regulatory requirements related to personal care and packaging markets continued to impact Industrial sales, although orders within both markets improved in the third quarter versus a year ago, reflecting a release of previously deferred projects. An increase in volumes within medical end markets also benefited sales. The Company completed the sale of its Seeger business on February 1, 2020, reducing sales by $14.1 million during the third quarter of 2020 relative to the prior year period. The decrease at Aerospace was driven by declines in sales within both the OEM and Aftermarket businesses, resulting primarily from a global slowdown in aerospace markets driven by COVID-19, and more specifically a resultant decline in aircraft utilization and the removal of aircraft from service by certain airlines. See additional discussion related to the anticipated financial impacts of COVID-19 within the segment outlooks below. See discussion related to COVID-19's risk on the Company's Consolidated Financial Statements within "Part II - Item 1A - Risk Factors." The weakening of the U.S. dollar against foreign currencies increased net sales within the Industrial segment by approximately $7.2 million.

The Company reported net sales of $835.3 million in the first nine months of 2020, a decrease of $285.7 million, or 25.5%, from the first nine months of 2019. Organic sales decreased by $246.9 million driven by decreases of $107.8 million at Industrial and $139.1 million at Aerospace. The sale of Seeger resulted in reduced sales of $38.7 million within the Industrial segment during the first nine months of 2020. Foreign currency did not impact Industrial sales on a nine month basis. The decreases at Industrial and Aerospace were driven by organic sales declines within the business units, again, due primarily to the impact of COVID-19 on our corresponding end markets.

Expenses and Operating Income


	Three Months Ended September 30,																		Nine Months Ended September 30,
(in millions)	2020			2019			Change							2020			2019		Change
Cost of sales	$	176.9		$	234.4		$	(57.5)	(24.5)	%	$	532.2		$	717.4		$	(185.2)	(25.8)	%
% sales	65.8		%	62.9		%					63.7		%	64.0		%
Gross profit ⁽¹⁾	$	92.2		$	138.2		$	(46.0)	(33.3)	%	$	303.1		$	403.6		$	(100.5)	(24.9)	%
% sales	34.2		%	37.1		%					36.3		%	36.0		%
Selling and administrative expenses	$	60.9		$	70.6		$	(9.7)	(13.7)	%	$	212.4		$	228.4		$	(16.0)	(7.0)	%
% sales	22.6		%	18.9		%					25.4		%	20.4		%
Operating income	$	31.2		$	67.6		$	(36.3)	(53.8)	%	$	90.7		$	175.2		$	(84.5)	(48.2)	%
% sales	11.6		%	18.1		%					10.9		%	15.6		%

(1) Sales less cost of sales.

Cost of sales in the third quarter of 2020 decreased 24.5% from the 2019 period and gross profit margin decreased from 37.1% in the 2019 period to 34.2% in the 2020 period. Gross margins declined at both Industrial and Aerospace. At Industrial, gross profit decreased primarily as a result of the reduced profit contribution of lower sales volumes, partially offset by the cost savings initiatives discussed above, including workforce reductions and employee furloughs. Within Aerospace, lower volumes within the maintenance overhaul and repair and spare parts businesses, in particular, contributed to declines in both gross profit and gross margin during the third quarter of 2020. Selling and administrative expenses in the third quarter of 2020 decreased 13.7% from the 2019 period on lower sales, primarily due to productivity and cost initiatives that included workforce reductions, as well as employee furloughs, temporary salaried employee pay reductions and discretionary spending initiatives. A reduction in employee related costs (including lower incentive compensation) also benefited the 2020 period. As a percentage of sales, selling and administrative costs increased from 18.9% in the third quarter of 2019 to 22.6% in the 2020 period. Operating income in the third quarter of 2020 decreased by 53.8% to $31.2 million compared with the third quarter of 2019 and operating income margin decreased from 18.1% to 11.6%, primarily driven by the items above.

Cost of sales in the first nine months of 2020 decreased 25.8% from the 2019 period, while gross profit margin increased from 36.0% in the 2019 period to 36.3% in the 2020 period. Gross margins improved at Industrial and declined at Aerospace. At Industrial, the gross margin increase during the first nine months of 2020 was primarily driven by the cost savings initiatives, as described above, combined with the absence of $5.4 million of short-term purchase accounting adjustments related to the acquisition of Gimatic. Within Aerospace, a reduction in gross profit in the first nine months of 2020 was driven by significantly lower volumes across the OEM and aftermarket businesses during the second and third quarters. Selling and administrative expenses in the first nine months of 2020 decreased 7.0% from the 2019 period. This reduction was driven partially by lower sales volumes, combined with cost savings initiatives, as discussed above. Also benefiting the current period was lower amortization of certain intangibles related to earlier acquisitions and a reduction in employee related costs (including lower incentive compensation). The primary drivers of lower selling and administrative expenses during the nine month period were partially offset by $18.0 million of pre-tax charges related to restructuring and workforce actions and $2.4 million of divestiture charges related to the completion of the Seeger sale. As a percentage of sales, selling and administrative costs increased from 20.4% in the first nine months of 2019 to 25.4% in the 2020 period. Operating income in the first nine months of 2020 decreased 48.2% to $90.7 million from the first nine months of 2019 and operating income margin decreased from 15.6% in the 2019 period to 10.9% in the 2020 period, primarily driven also by the items noted above.

Interest expense

Interest expense decreased by $1.6 million in the third quarter of 2020 and by $3.9 million in the first nine months of 2020 as compared with the prior year periods, primarily a result of decreased average borrowings and lower average interest rates.

Other expense (income), net

Other expense (income), net in the third quarter of 2020 was approximately $0.1 million compared to $2.5 million in the third quarter of 2019. Other expense (income) in the current period included a foreign currency gain of $0.4 million as compared with a foreign currency loss of $2.2 million in the 2019 period. Other expense (income), net in the first nine months of 2020 was $2.7 million compared to $6.0 million in the first nine months of 2019. Foreign currency gains of $0.3 million in the first nine months of 2020 compared with foreign currency losses of $4.2 million in the first nine months of 2019.

Income Taxes

The Company's effective tax rate for the first nine months of 2020 was 40.0% compared with 23.4% in the first nine months of 2019 and 23.4% for the full year 2019. The increase in the first nine months of 2020 effective tax rate from the full year 2019 rate is primarily due to a decrease in projected earnings in jurisdictions with lower rates, the recognition of tax expense related to the completed sale of the Seeger business during the first quarter of 2020 ($4.2 million), the impact of the global intangible low-taxed income tax on foreign earnings in the U.S. (despite lower U.S. income) and excess tax charges related to stock awards. The impact of these items was partially offset by a benefit related to a refund of withholding taxes that were previously paid and included in tax expense in prior years and a reduction of the statutory tax rate at one of our international operations, both of which were recognized in the first quarter of 2020. The full year 2020 effective tax rate is forecasted to approximate 39%, which includes the recognition of tax expense related to the sale of the Seeger business.

Income and Income per Share


	Three Months Ended September 30,														Nine Months Ended September 30,
(in millions, except per share)	2020		2019		Change						2020		2019		Change
Net income	$	15.4	$	45.8	$	(30.4)	(66.4)	%	$	45.7	$	117.4	$	(71.7)	(61.1)	%
Net income per common share:
Basic	$	0.30	$	0.90	$	(0.60)	(66.7)	%	$	0.90	$	2.29	$	(1.39)	(60.7)	%
Diluted	0.30		0.89		(0.59)		(66.3)	%	0.89		2.27		(1.38)		(60.8)	%
Weighted average common shares outstanding:
Basic	50.8		50.9		(0.1)		(0.2)	%	50.9		51.3		(0.4)		(0.8)	%
Diluted	50.9		51.2		(0.3)		(0.6)	%	51.1		51.7		(0.6)		(1.2)	%

Basic and diluted net income per common share decreased for the three and nine month periods as compared to 2019. The decreases were due to lower net income for the periods. Basic and diluted weighted average common shares outstanding decreased due to the repurchase of 900,000 and 396,000 shares during 2019 and 2020, respectively, as part of the Company's publicly announced Repurchase Program. The impact of the repurchased shares was partially offset by the issuance of additional shares for employee stock plans.

Financial Performance by Business Segment

Industrial


	Three Months Ended September 30,																		Nine Months Ended September 30,
(in millions)	2020			2019			Change							2020			2019		Change
Sales	$	196.9		$	231.7		$	(34.8)	(15.0)	%	$	561.0		$	707.6		$	(146.5)	(20.7)	%
Operating profit	24.4			34.8			(10.4)		(29.8)	%	42.1			83.8			(41.7)		(49.8)	%
Operating margin	12.4		%	15.0		%					7.5		%	11.8		%

Sales at Industrial were $196.9 million in the third quarter of 2020, a $34.8 million, or 15.0% decrease from the third quarter of 2019. Organic sales decreased by $27.9 million, or 12.0%, during the 2020 period, driven by lower sales across the businesses, primarily driven by the impact of COVID-19. The Automation business experienced slight growth in organic sales as compared with the prior period. On a sequential basis, Industrial sales increased by 19.3% between the second and third quarters of 2020, providing indications of a gradual recovery during the third quarter of 2020. Global automotive production rates also improved during the third quarter of 2020, benefiting Industrial sales during the period. Delays in automotive model changes releases remained, resulting from the impacts of both COVID-19 and broader economic uncertainty, as customers continue to defer certain capital expenditures. Within the personal care and packaging markets, proposed environmental regulations affecting product composition and disposability continue to impact sales and orders. However, orders within both markets improved year-over-year, reflecting the release of some previously deferred projects. Sequential sales within both of these markets improved in the third quarter of 2020. An increase in volumes within medical end markets also benefited Industrial sales. The Company completed the sale of its Seeger business in February 2020, reducing sales by $14.1 million during the third quarter of 2020 relative to the prior year period. See additional discussion below and within "Part II - Item 1A - Risk Factors". Foreign currency increased sales by approximately $7.2 million as the U.S. dollar weakened against foreign currencies. During the first nine months of 2020, this segment reported sales of $561.0 million, a 20.7% decrease from the first nine months of 2019. Organic sales decreased by $107.8 million, or 15.2%, during the 2020 period, primarily a result of COVID-19 and automotive related declines in sales within the businesses. The divestiture of Seeger reduced sales by $38.7 million during the first nine months of 2020 relative to the prior year period, whereas foreign currency did not impact sales on a nine month basis.

The operating profit in the third quarter of 2020 at Industrial was $24.4 million, a decrease of $10.4 million from the third quarter operating profit of $34.8 million in 2019. Operating profit was negatively impacted by the lower profit contribution of declining organic sales volumes resulting from COVID-19, partially offset by the benefits of cost initiatives that were taken throughout 2020, including workforce reductions, as well as employee furloughs, temporary salaried employee pay reductions and discretionary spending initiatives. Government incentives in certain regions also served as a benefit to operating profit. Operating margin decreased from 15.0% in the 2019 period to 12.4% in the 2020 period, driven primarily by the items described above. Operating profit in the first nine months of 2020 was $42.1 million, a decrease of $41.7 million from the first nine months of 2019, driven by the profit impact of lower organic sales, $15.8 million of restructuring charges and $2.4 million of divestiture charges related to the completion of the Seeger sale, partially offset by the cost initiatives discussed above. Lower intangible amortization and a reduction in employee related costs (including lower incentive compensation) partially offset the profit impact of lower volumes and restructuring charges during the first nine months of 2020. The first nine months of 2019 included $5.4 million of short-term purchase accounting adjustments related to the acquisition of Gimatic and a favorable $2.6 million settlement related to a commercial matter. Operating margin decreased from 11.8% in the 2019 period to 7.5% in the 2020 period, primarily as a result of the items described above.

Outlook: In Industrial, management remains focused on generating organic sales growth through the introduction of new products and services and by leveraging the benefits of its diversified products and global industrial end-markets, however the onset of COVID-19 has presented new challenges for the Company during 2020. Our ability to generate sales growth is impacted by recent disruptions within the global markets served by all of our businesses. Entering 2020, automotive, tool and die, and personal care and packaging end markets were experiencing lingering softness. Given the onset of COVID-19, sales pressure increased further within these markets, as described above. Markets within our key regions of China, Europe and North America have recently begun to indicate signs of recovery, however markets remain challenged given continued uncertainty within our end-markets. Several automotive plants, including plants operated by certain of our more significant customers, experienced closures earlier in the year. Although a majority of these facilities have since returned to production, demand and manufacturing capacity has been impacted by the conditions across our end-markets. General industrial end markets remain relatively soft, however we have seen a gradual recovery in sales during the third quarter of 2020 as the global economic environment improves. It is expected that conditions within the general industrial market will continue to improve as the broader economy recovers. Medical end markets are expected to remain favorable. For overall industrial end-markets, the manufacturing Purchasing Managers' Index ("PMI") reflect the impacts of COVID-19. PMI within the United States, Europe

and China initially deteriorated to below 50 (indicating contraction) between December 31, 2019 and March 31, 2020. PMIs subsequently improved through September 30, 2020, with all regions rising to above 50. Global forecasted production for light vehicles has improved within the Europe, China and North America markets during the third quarter of 2020, a positive sign for our businesses. Within our Molding Solutions business, the global medical market remains healthy. While automotive production has showed improvement during the current quarter, the automotive hot runner market remains soft given a continued delay in model launches by automotive original equipment manufacturers (further intensified by the impacts of COVID-19). Current quarter orders within packaging and personal care markets have improved sequentially since the second quarter of 2020, however proposed environmental regulations affecting product and packaging composition and disposability may impact future sales within these end markets. Overall industrial end-markets may also be impacted by uncertainty related to current and proposed tariffs announced by the United States and the China governments, although developments in this area have been muted given the global shift in focus to combating COVID-19. As noted above, foreign currency did not impact sales on a nine month basis. To the extent that the U.S. dollar fluctuates relative to other foreign currencies, our sales may be impacted by foreign currency relative to the prior year periods. The relative impact on operating profit is not expected to be as significant as the impact on sales as most of our businesses have expenses primarily denominated in local currencies, where their revenues reside, however operating margins may be impacted. Although the Company's near-term focus remains on the preservation of cash and liquidity given the disruption caused by COVID-19, the Company remains focused long term on sales growth through innovation, acquisition and expanding geographic reach. Strategic investments in new technologies, manufacturing processes and product development are expected to provide benefits over the long term and management continues to evaluate such opportunities.

Given the recent pressures on sales resulting from COVID-19, the Company is focused on the proactive management of costs to mitigate the impacts on operating profit. Management also remains focused on strategic investments and new product and process introductions, as well as driving productivity by leveraging the Barnes Enterprise System. Recent cost saving initiatives taken earlier in 2020 include the workforce reductions described above, in addition to employee furloughs, temporary salaried employee pay reductions and discretionary spending initiatives. The Company continues to manage its cost structure to align with the intake of order and sales. Management will continue to explore opportunities for additional cost savings throughout the remainder of 2020, including working closely with vendors and customers as it relates to the timing of deliveries and pricing initiatives. It is anticipated that operating profit will continue to be impacted by changes in sales volume noted above, mix and pricing, and the levels of short term investments made within each of the Industrial businesses. Operating profit may also be impacted by enactment of or changes in tariffs, trade agreements and trade policies that may affect the cost and/or availability of goods, including aluminum and steel. Costs associated with new product and process introductions, restructuring and other cost initiatives, strategic investments and the integration of acquisitions may negatively impact operating profit.

Aerospace


	Three Months Ended September 30,																		Nine Months Ended September 30,
(in millions)	2020			2019			Change							2020			2019		Change
Sales	$	72.1		$	140.9		$	(68.8)	(48.8)	%	$	274.2		$	413.4		$	(139.1)	(33.7)	%
Operating profit	6.8			32.7			(25.9)		(79.2)	%	48.6			91.4			(42.8)		(46.8)	%
Operating margin	9.4		%	23.2		%					17.7		%	22.1		%

The Aerospace segment reported sales of $72.1 million in the third quarter of 2020, a 48.8% decrease from the third quarter of 2019. Sales declined within both the OEM and the aftermarket businesses relative to the 2019 period. The decline in OEM sales was largely attributed to COVID-19 which severely impacted the aerospace industry in the second and third quarter and, to a lesser extent, 737 Max aircraft delays, following a suspension of production by Boeing. OEM sales, more specifically, were impacted by a reduction in engine and airframe build schedules, in addition to growing levels of inventory that already exist within the supply chain. Sales within the aftermarket repair and overhaul ("MRO") and spare parts businesses also declined during the third quarter of 2020 as airline traffic and aircraft utilization severely declined as a result of COVID-19, with the removal of aircraft from service by certain airlines resulting in unprecedented reductions in demand. See additional discussion below and within Part II, Item 1A. On a sequential basis, however, Aerospace sales improved by 2.3% in the third quarter of 2020, relative to the second quarter of 2020. The sales mix within the businesses varied on a sequential basis, as OEM sales improved by 17% and aftermarket sales declined by 22% between the second and third quarters of 2020. Sales within the segment are largely denominated in U.S. dollars and therefore were not significantly impacted by changes in foreign currency. During the first nine months of 2020, the Aerospace segment reported sales of $274.2 million, a 33.7% decrease from the first nine months of 2019, also driven by decline within both of the Aerospace businesses. The sales decline during the first nine months of 2020 also resulted from lower sales volumes due to the impact of COVID-19, as noted above.

Operating profit at Aerospace in the third quarter of 2020 decreased 79.2% from the third quarter of 2019 to $6.8 million. The operating profit decrease resulted from the profit impact of lower volumes within each of the businesses, as discussed above, and $0.3 million of restructuring charges, partially offset by productivity and cost savings initiatives including reductions in workforce, as well as employee furloughs, reduced overtime, temporary pay reductions within leadership, lower overtime and discretionary spending initiatives. Government incentives in certain regions also served as a benefit to operating margins. Reductions in employee related costs (including lower incentive compensation) also serve as a partial offset to the profit impact of lower volumes. Operating margin decreased from 23.2% in the 2019 period to 9.4% in the 2020 period primarily as a result of lower demand across the businesses. Operating profit in the first nine months of 2020 decreased 46.8% from the first nine months of 2019 to $48.6 million, also driven by lower sales volumes and $2.2 million of restructuring charges that were recorded during 2020, primarily employee severance and other termination benefits, partially offset by lower incentive compensation, cost savings initiatives and government incentives described above.

Outlook: Sales in the Aerospace OEM business are based on the general state of the aerospace market driven by the worldwide economy and are supported by its order backlog through participation in certain strategic commercial and military engine and airframe programs. With the onset of COVID-19, previously strong aerospace end markets have come under severe pressure, driving OEM sales declines of roughly 50% and 45% in the second and third quarters of 2020, respectively, as compared with respective 2019 periods. The OEM business is continuing to experience challenges in 2020 relative to the prior year period based on lower aircraft demand and production cuts at Boeing and Airbus. The duration and depth of the aerospace market disruptions remain uncertain at this time, however a recovery to pre-pandemic levels is expected to take several years. Aerospace management continues to work with customers to evaluate engine and airframe build schedules, giving management the ability to react timely to such changes. Management is also working closely with suppliers to align raw material schedules with production requirements. Management remains focused on executing long-term agreements, while expanding its share of production on key programs. Backlog at OEM was $534.2 million at September 30, 2020, a decrease of 33.3% since December 31, 2019, at which time backlog was $800.7 million (24.0% decline from backlog of $703.1 million as of March 31, 2020 and 3.8% decline from backlog of $555.2 as of June 30, 2020), with a significant portion of this decline resulting from changes in General Electric and Rolls-Royce production schedules for aircraft engines. If COVID-19 continues to have a material impact on the aviation industry, including our more significant OEM customers, it will continue to materially affect our Aerospace business and results of operations. Backlog may decline further as Aerospace customers adjust orders based on their changing aircraft production schedules. Approximately 45% of OEM backlog is currently scheduled to ship in the next 12 months. The Aerospace OEM business may also be impacted by changes in the content levels on certain platforms, changes in customer sourcing decisions, adjustments to customer inventory levels, commodity availability and pricing, vendor sourcing capacity and the use of alternate materials. Additional impacts may include the redesign of parts, quantity of parts per engine, cost schedules agreed to under contract with the engine and airframe manufacturers, as well as the pursuit and duration of new programs.

In the Aerospace aftermarket business, COVID-19 is impacting previously strong aerospace end markets. Significantly reduced aircraft utilization, increased levels of aircraft removed from service, and reduced airline profitability are expected to continue to negatively impact our business in the mid-term. Sales in the Aerospace aftermarket business may continue to be impacted by inventory management and changes in customer sourcing, deferred or limited maintenance activity during engine shop visits and the use of surplus (used) material during the engine repair and overhaul process. Management believes that its Aerospace aftermarket business continues to be competitively positioned based on well-established long-term customer relationships, including maintenance and repair contracts in the MRO business and long-term Revenue Sharing Programs ("RSPs") and Component Repair Programs ("CRPs"). The MRO business may also be impacted by airlines that closely manage their aftermarket costs as engine performance and quality improves. Fluctuations in fuel costs and their impact on airline profitability and behaviors within the aerospace industry could also impact levels and frequency of aircraft maintenance and overhaul activities, and airlines' decisions on maintaining, deferring or canceling new aircraft purchases, in part based on the economics associated with new fuel efficient technologies.

Given the recent pressures on sales growth resulting from COVID-19, the Company is focused on the proactive management of costs as it takes action to mitigate continued pressure on operating profit. Recent cost saving initiatives that were taken earlier in 2020 include workforce reductions, employee furloughs, reduced overtime, temporary pay reductions within leadership and discretionary spending initiatives. Although taken in an earlier period, these actions were critical in partially offsetting the lower profit contribution of lower sales in the current period. Aerospace will continue to explore opportunities for additional cost savings throughout the remainder of 2020 and into 2021, including working closely with vendors and customers as it relates to the timing of deliveries and pricing initiatives. Management also remains focused on strategic investments and new product and process introductions. Driving productivity through the application of the Barnes Enterprise System continues as a key initiative. Operating profit is expected to be affected by the impact of the changes in sales volume noted above, mix and pricing, particularly as they relate to the higher profit aftermarket RSP spare parts business, and investments made in each of its businesses. Operating profits may also be impacted by potential changes in tariffs, trade agreements and trade policies that may

affect the cost and/or availability of goods. Costs associated with new product and process introductions, the physical transfer of work to other global regions, additional productivity initiatives and restructuring activities may also negatively impact operating profit.

LIQUIDITY AND CAPITAL RESOURCES

Management assesses the Company's liquidity in terms of its overall ability to generate cash to fund its operating and investing activities. Of particular importance in the management of liquidity are cash flows generated from operating activities, capital expenditure levels, dividends, capital stock transactions, effective utilization of surplus cash positions overseas and adequate lines of credit. The Company currently maintains sufficient liquidity and will continue to evaluate ways to enhance its liquidity position as it navigates through the disrupted business environment that has resulted from COVID-19.

The Company believes that its ability to generate cash from operations in excess of its internal operating needs is one of its financial strengths. Management continues to focus on cash flow and working capital management, and anticipates that operating activities in 2020 will generate sufficient cash to fund operations. Given the recent global market disruptions caused by COVID-19, the Company is closely monitoring its cash generation, usage and preservation including the management of working capital to generate cash. The Company does not currently anticipate requiring any additional debt facilities. See additional discussion regarding currently available debt facilities further below.

To better align costs with the current business environment, the Company has taken several actions. In June 2020, the Company announced restructuring and workforce reduction actions ("actions") to be implemented across its businesses and functions in response to the macroeconomic disruption in global industrial and aerospace end markets arising from COVID-19. A resulting pre-tax charge of $18.0 million was recorded through operating profit in 2020, primarily related to employee severance and other termination benefits, with the amounts expected to be paid by the end of 2021, primarily using cash on hand. These actions are expected to be substantially completed in 2020 and reduce the Company’s global workforce by approximately 8%. A liability of $15.1 million was included within accrued liabilities as of September 30, 2020. The Company expects to incur additional costs of approximately $2.0 million through the first half of 2021 related to these actions. Additional cost saving initiatives include temporary reductions in compensation for salaried employees, including Company officers and Board directors, employee furloughs and reductions in discretionary expenses. The Company continues to invest within its businesses, with its estimate of 2020 capital spending being lowered to approximately $40 million from the beginning of the year.

In February 2017, the Company and certain of its subsidiaries entered into the fourth amendment of its fifth amended and restated revolving credit agreement (the “Amended Credit Agreement”) and retained Bank of America, N.A. ("Bank of America") as the Administrative Agent for the lenders. The Amended Credit Agreement increased the facility from $750.0 million to $850.0 million and extends the maturity date from September 2018 to February 2022. The Amended Credit Agreement also increases the existing accordion feature from $250.0 million, allowing the Company to request additional borrowings of up to $350.0 million. The Company may exercise the accordion feature upon request to the Administrative Agent as long as an event of default has not occurred or is not continuing. The borrowing availability of $850.0 million, pursuant to the terms of the Amended Credit Agreement, allows for multi-currency borrowing which includes Euro, British pound sterling or Swiss franc borrowing, up to $600.0 million. In September 2018, the Company and one of its wholly owned subsidiaries entered into a Sale and Purchase Agreement to acquire Gimatic S.r.l. In conjunction with the acquisition, the Company requested additional borrowings of $150.0 million that was provided for under the existing accordion feature. The Administrative Agent for the lenders approved the Company's access to the accordion feature and on October 19, 2018 the lenders formally committed the capital to fund such feature, resulting in the execution of the fifth amendment to the Amended Credit Agreement (the "Fifth Amendment"). The Fifth Amendment, effective October 19, 2018, thereby increased the borrowing availability of the existing facility to $1,000.0 million. The Company may also request access to the residual $200.0 million of the accordion feature. Depending on the Company’s consolidated leverage ratio, and at the election of the Company, borrowings under the Amended Credit Agreement will bear interest at either LIBOR plus a margin of between 1.10% and 1.70% or the base rate, as defined in the Amended Credit Agreement, plus a margin of 0.10% to 0.70%. Multi-currency borrowings, pursuant to the Amended Credit Agreement, bear interest at their respective interbank offered rate (i.e. Euribor) or 0.00% (higher of the two rates) plus a margin of between 1.10% and 1.70%.

In October 2014, the Company entered into a Note Purchase Agreement (“Note Purchase Agreement”), among the Company and New York Life Insurance Company, New York Life Insurance and Annuity Corporation and New York Life Insurance and Annuity Corporation Institutionally Owned Life Insurance Separate Account, as purchasers, for the issuance of $100.0 million aggregate principal amount of 3.97% senior notes due October 17, 2024 (the “3.97% Senior Notes”). The 3.97% Senior Notes are senior unsecured obligations of the Company and pay interest semi-annually on April 17 and October 17 of each year at an annual rate of 3.97%. The 3.97% Senior Notes will mature on October 17, 2024 unless earlier prepaid in accordance with their

terms. Subject to certain conditions, the Company may, at its option, prepay all or any part of the 3.97% Senior Notes in an amount equal to 100% of the principal amount of the 3.97% Senior Notes so prepaid, plus any accrued and unpaid interest to the date of prepayment, plus the Make-Whole Amount, as defined in the Note Purchase Agreement, with respect to such principal amount being prepaid. The Note Purchase Agreement contains customary affirmative and negative covenants that are similar to the covenants required under the Amended Credit Agreement, as discussed below. At September 30, 2020, the Company was in compliance with all covenants under the Note Purchase Agreement.

The Company's borrowing capacity is limited by various debt covenants in the Amended Credit Agreement and the Note Purchase Agreement (the "Agreements"). At September 30, 2020, the Agreements require the Company to maintain a ratio of Consolidated Senior Debt, as defined, to Consolidated EBITDA, as defined, of not more than 3.25 times ("Senior Debt Ratio"), a ratio of Consolidated Total Debt, as defined, to Consolidated EBITDA of not more than 3.75 times ("Total Debt Ratio") and a ratio of Consolidated EBITDA to Consolidated Cash Interest Expense, as defined, of not less than 4.25, in each case at the end of each fiscal quarter; provided that the debt to EBITDA ratios are permitted to increase for a period of four fiscal quarters after the closing of certain permitted acquisitions. A permitted acquisition is defined as an acquisition exceeding $150.0 million, for which the acquisition of Gimatic qualified. With the completion of a permitted acquisition, the Senior Debt Ratio cannot exceed 3.50 times and the Total Debt Ratio cannot exceed 4.25 times. The increased ratios are allowed for a period of four fiscal quarters subsequent to the close of the permitted acquisition and therefore expired in the fourth quarter of 2019.

On October 8, 2020, the Company entered into the sixth amendment to the Amended Credit Agreement with Bank of America (the “Sixth Amendment”) and the first amendment to the Note Purchase Agreement with New York Life (the “First NPA Amendment”). The Sixth Amendment and the First NPA Amendment provided for an increase in the Company’s maximum ratio of Consolidated Senior Debt, as defined, to Consolidated EBITDA, as defined, from 3.25 times (or, if a certain permitted acquisition above $150,000 is consummated, 3.50 times) to 3.75 times in each case at the end of the four fiscal quarters, beginning with December 31, 2020, providing additional financing flexibility and access to liquidity. Additionally, the Sixth Amendment requires the Company to maintain a maximum ratio of Consolidated Total Debt, as defined, to Consolidated EBITDA, of not more than 3.75 times in each case at the end of the four fiscal quarters, beginning with December 31, 2020 and regardless of whether a permitted acquisition, as defined, is consummated. Furthermore, the First NPA Amendment provides for (i) adjustments to the ratio of Consolidated Total Debt, as defined, to Consolidated EBITDA, as defined, to conform to a more restrictive total leverage ratio that may be required under the Amended Credit Agreement, (ii) an increase in the amount of allowable add-back for restructuring charges when calculating Consolidated EBITDA from $15,000 to $25,000 and (iii) a required fee payment equal to 0.50% per annum times the daily outstanding principal amount of the note during each of the four fiscal quarters, following the quarter ended December 31, 2020, if the Company’s Senior Leverage Ratio, as defined, exceeds 3.25 times.

At September 30, 2020, the Company was in compliance with all covenants under the Agreements. The Company anticipates continued compliance under the Agreements in each of the next four quarters. The Company's most restrictive financial covenant is the Senior Debt Ratio, which required the Company to maintain a ratio of Consolidated Senior Debt to Consolidated EBITDA of not more than 3.25 times at September 30, 2020. The actual ratio at September 30, 2020 was 2.76 times, as defined.

During the first quarter of 2020, the Company repurchased 0.4 million shares of the Company's stock under the publicly announced Repurchase Program, at a cost of $15.6 million. During the second quarter of 2020, however, management suspended share repurchase activity as a result of COVID-19, and therefore no shares were repurchased during the second or third quarters of 2020. Given the uncertainty of the current business environment, the Company does not have an expected timeframe as to when share repurchases will resume. See "Part II - Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds".

Operating cash flow may be supplemented with external borrowings to meet near-term business expansion needs and the Company's current financial commitments. The Company has assessed its credit facilities in conjunction with the Amended Credit Facility and currently expects that its bank syndicate, comprised of 14 banks, will continue to support its Amended Credit Agreement which matures in February 2022. At September 30, 2020, the Company had $402.9 million unused and available for borrowings under its $1,000.0 million Amended Credit Facility, subject to covenants in the Company's revolving debt agreements. At September 30, 2020, additional borrowings of $256.1 million of Total Debt including $126.3 million of Senior Debt would have been allowed under the financial covenants. The Company intends to use borrowings under its Amended Credit Facility to support the Company's ongoing growth initiatives, however the probability of an acquisition or divestiture in the near-term is unlikely given the current business environment. Nonetheless, the Company continues to analyze potential acquisition targets and end markets that meet our strategic criteria with an emphasis on proprietary, highly-engineered industrial technologies. The Company believes its credit facilities and access to capital markets, coupled with cash generated from operations, are adequate for its anticipated future requirements. At this time, the Company has not drawn on its debt

agreements as a result of COVID-19, as it believes the availability of those funds are not at risk given the strength of the underlying bank syndicate. The Company maintains communication with its bank syndicate as it continues to monitor its cash requirements.

The Company had $14.3 million in borrowings under short-term bank credit lines at September 30, 2020.

The Company entered into an interest rate swap agreement (the "Swap") on April 28, 2017, with one bank, which converts the interest on the first $100.0 million of the Company's one-month LIBOR-based borrowings from a variable rate plus the borrowing spread to a fixed rate of 1.92% plus the borrowing spread. The swap expires on January 31, 2022. At September 30, 2020, the Company's total borrowings were comprised of approximately 29% fixed rate debt and 71% variable rate debt. At December 31, 2019, the Company's total borrowings were comprised of approximately 25% fixed rate debt and 75% variable rate debt.

The Company completed the sale of the Seeger business to KNG effective February 1, 2020. Gross proceeds received were 39.6 million Euros ($43.7 million). The Company yielded net cash proceeds of $36.9 million after consideration of cash sold and transaction costs. The final amount of proceeds from the sale is subject to post-closing adjustments. Resulting tax charges of $4.2 million were recognized in the first quarter of 2020 following the completion of the sale. The Company utilized the proceeds from the sale to reduce debt under the Amended Credit Facility.

At September 30, 2020, the Company held $77.5 million in cash and cash equivalents, the majority of which was held by foreign subsidiaries. These amounts have no material regulatory or contractual restrictions and are expected to primarily fund international investments.

In 2019, the Company contributed $15.0 million of discretionary contributions to its U.S Qualified pension plans. The Company currently does not plan to make any additional discretionary contributions to its U.S. Qualified pension plans, however approximately $4.4 million is expected to be made into its U.S. Non-qualified and international pension plans throughout 2020.

Cash Flow


	Nine Months Ended September 30,
(in millions)	2020		2019		Change
Operating activities	$	163.4	$	161.3	$	2.1
Investing activities	0.7		(43.6)		44.2
Financing activities	(181.1)		(134.8)		(46.3)
Exchange rate effect	0.7		(3.2)		3.9
Decrease in cash	$	(16.3)	$	(20.3)	$	3.9

Operating activities provided $163.4 million in the first nine months of 2020 compared to $161.3 million in the first nine months of 2019. Operating cash flows in the 2020 period included cash generated by working capital of $67.1 million, which was driven by a reduction in accounts receivable, compared to cash used by working capital of $3.7 million in the 2019 period. Operating cash flows in the 2019 period were negatively impacted by a $15.0 million discretionary contribution made to the U.S. qualified pension plans.

Investing activities generated $0.7 million in the first nine months of 2020 and used $43.6 million in the first nine months of 2019. Net cash proceeds of $36.9 million, less $6.6 million which is classified as restricted cash (recorded within other assets

on the Consolidated Balance Sheet as of September 30, 2020), from the sale of the Seeger business are included in investing activities for the 2020 period. See Note 2 of the Consolidated Financial Statements. Investing activities in the 2020 period also included capital expenditures of $30.2 million compared to $37.7 million in the 2019 period. The Company expects capital spending in 2020 to approximate $40 million. Investing activities in the 2019 period also included $6.1 million of payments related to the Gimatic acquisition under the terms of the Sale and Purchase Agreement.

Financing activities in the first nine months of 2020 included a net decrease in borrowings of $137.5 million compared to $43.6 million in the comparable 2019 period. In 2019, the Company borrowed 44.1 million Euros ($49.5 million) under the Amended Credit Facility through an international subsidiary. The proceeds were distributed to the Parent Company and subsequently used to pay down U.S. borrowings under the Amended Credit Agreement. During the first nine months of 2020 and 2019, the Company repurchased 0.4 million shares and 0.9 million shares, respectively, of the Company's stock at a cost of $15.6 million and $50.3 million, respectively. Total cash used to pay dividends was $24.3 million in the 2020 period compared to $24.4 million in the 2019 period. Other financing cash flows during the first nine months of 2020 and 2019 include $1.9 million and $12.6 million, respectively, of net cash payments resulting from the settlement of foreign currency hedges related to intercompany financing.

The Company maintains borrowing facilities with banks to supplement internal cash generation. At September 30, 2020, $597.1 million was borrowed at an average interest rate of 1.22% under the Company's $1,000.0 million Amended Credit Facility which matures in February 2022. In addition, as of September 30, 2020, the Company had $14.3 million in borrowings under short-term bank credit lines. At September 30, 2020, the Company's total borrowings were comprised of 29% fixed rate debt and 71% variable rate debt. The interest payments on $100.0 million of the variable rate interest debt have been converted into payment of fixed interest plus the borrowing spread under the terms of the respective interest rate swap that was executed in April 2017.

Debt Covenants

As noted above, borrowing capacity is limited by various debt covenants in the Company's debt agreements. Following is a reconciliation of Consolidated EBITDA, a key metric in the debt covenants, to the Company's net income (in millions):


	Four fiscal quarters ended September 30, 2020
Net income	$	86.6
Add back:
Interest expense	16.7
Income taxes	43.0
Depreciation and amortization	89.4
Adjustment for non-cash stock based compensation	11.5
Amortization of Gimatic acquisition inventory step-up	(3.3)
Workforce reduction and restructuring charges (see Note 17)	15.0
Due diligence and transaction expenses	2.9
Non-cash impairment charge (see Note 2)	5.6
Other adjustments	(7.7)
Consolidated EBITDA, as defined within the Amended Credit Agreement	$	259.7

Consolidated Senior Debt, as defined, as of September 30, 2020	$	717.7
Ratio of Consolidated Senior Debt to Consolidated EBITDA	2.76
Maximum	3.25
Consolidated Total Debt, as defined, as of September 30, 2020	$	717.7
Ratio of Consolidated Total Debt to Consolidated EBITDA	2.76
Maximum	3.75
Consolidated Cash Interest Expense, as defined, as of September 30, 2020	$	16.7
Ratio of Consolidated EBITDA to Consolidated Cash Interest Expense	15.55
Minimum	4.25

The Amended Credit Agreement allows for certain adjustments within the calculation of the financial covenants. As defined within the Note Purchase Agreement governing the 3.97% Senior Notes, restructuring charges added back to EBITDA for debt covenant purposes is limited to $15.0 million over a four fiscal quarter period (as of September 30, 2020). Per the First NPA Amendment, the restructuring charges added back to EBITDA for debt covenant purposes was increased from $15.0 million to $25.0 million for a period of four fiscal quarters beginning with the quarter ended December 31, 2020. Other adjustments consist primarily of changes in accounting as permitted under the Amended Credit Agreement. The Company's financial covenants are measured as of the end of each fiscal quarter. At September 30, 2020, additional borrowings of $256.1 million of Total Debt including $126.3 million of Senior Debt would have been allowed under the covenants. Senior Debt includes primarily the borrowings under the Amended Credit Facility, the 3.97% Senior Notes and the borrowings under the lines of credit. The Company's unused committed credit facilities at September 30, 2020 were $402.9 million; however, the borrowing capacity was limited by the debt covenants to $126.3 million at September 30, 2020.

OTHER MATTERS

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant accounting policies are disclosed in Note 1 of the Consolidated Financial Statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. The most significant areas involving management judgments and estimates are described in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. Actual results could differ from those estimates. There have been no material changes to such judgments and estimates.

Critical Accounting Policies

Goodwill and Indefinite-Lived Intangible Assets: Goodwill and indefinite-lived intangible assets are subject to impairment testing annually or earlier if an event or change in circumstances indicates that the fair value of a reporting unit has been reduced below its carrying value. Management completes their annual impairment assessments during the second quarter of each year as of April 1. The Company utilizes the option to first assess qualitative factors to determine whether it is necessary to perform the Step 1 quantitative goodwill impairment test in accordance with the applicable accounting standards. Under the qualitative assessment, management considers relevant events and circumstances including but not limited to macroeconomic conditions, industry and market considerations, overall unit performance and events directly affecting a unit. If the Company determines that the Step 1 quantitative impairment test is required, management estimates the fair value of the reporting unit primarily using the income approach, which reflects management’s cash flow projections, and also evaluates the fair value using the market approach. Inherent in management’s development of cash flow projections are assumptions and estimates, including those related to future earnings and growth and the weighted average cost of capital. The Company compares the fair value of the reporting unit with the carrying value of the reporting unit. If the fair values were to fall below the carrying values, the Company would recognize a non-cash impairment charge to income from operations for the amount by which the carrying amount of any reporting unit exceeds the reporting unit’s fair value, assuming the loss recognized does not exceed the total amount of goodwill for the reporting unit. Based on our second quarter assessment, the estimated fair value of the Automation reporting unit, which represents the 2018 acquisition of Gimatic, exceeded its carrying value while the estimated fair value of each of the remaining reporting units significantly exceeded their carrying values. There was no goodwill impairment at any reporting units. Many of the factors used in assessing fair value are outside the control of management, and these assumptions and estimates can change in future periods as a result of both Company-specific and overall economic conditions, including the impacts of COVID-19. Management’s quantitative assessment includes a review of the potential impacts of current and projected market conditions from a market participant’s perspective on reporting units’ projected cash flows, growth rates and cost of capital to assess the likelihood of whether the fair value would be less than the carrying value. The Company also completed its annual impairment testing of its trade names, indefinite-lived intangible assets, in the second quarter of 2020 and determined that there were no impairments.

EBITDA

Earnings before interest expense, income taxes, and depreciation and amortization ("EBITDA") for the first nine months of 2020 was $154.0 million compared to $244.8 million in the first nine months of 2019. EBITDA is a measurement not in accordance with generally accepted accounting principles (“GAAP”). The Company defines EBITDA as net income plus interest expense, income taxes, and depreciation and amortization which the Company incurs in the normal course of business. The Company does not intend EBITDA to represent cash flows from operations as defined by GAAP, and the reader should not consider it as an alternative to net income, net cash provided by operating activities or any other items calculated in accordance with GAAP, or as an indicator of the Company's operating performance. The Company's definition of EBITDA may not be

comparable with EBITDA as defined by other companies. The Company believes EBITDA is commonly used by financial analysts and others in the industries in which the Company operates and, thus, provides useful information to investors. Accordingly, the calculation has limitations depending on its use.

Following is a reconciliation of EBITDA to the Company's net income (in millions):


	Nine Months Ended September 30,
	2020		2019
Net income	$	45.7	$	117.4
Add back:
Interest expense	11.9		15.9
Income taxes	30.4		35.9
Depreciation and amortization	66.0		75.7
EBITDA	$	154.0	$	244.8

FORWARD-LOOKING STATEMENTS

Certain of the statements in this quarterly report contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements do not constitute guarantees of future performance and are subject to a variety of risks and uncertainties that may cause actual results to differ materially from those expressed in the forward-looking statements. These include, among others: difficulty maintaining relationships with employees, customers, distributors, suppliers, business partners or governmental entities; failure to successfully negotiate collective bargaining agreements or potential strikes, work stoppages or other similar events; difficulties leveraging market opportunities; changes in market demand for our products and services; rapid technological and market change; the ability to protect and avoid infringing upon intellectual property rights; introduction or development of new products or transfer of work; higher risks in global operations and markets; the impact of intense competition; acts of terrorism, cybersecurity attacks or intrusions that could adversely impact our businesses; the impacts of the COVID-19 pandemic on our business, including on demand, supply chains, operations and our ability to maintain sufficient liquidity throughout the unknown duration and severity of the crisis; the failure to achieve anticipated cost savings and benefits associated with the workforce reductions and restructuring actions previously announced by the Company (the “Plan”); the ability to successfully execute the Plan; the preliminary nature of our cost and savings estimates related to the Plan, including the timing of such charges and savings, which are subject to change as the Company makes decisions and refines estimates over time; timing delays in implementing the Plan; management and employee distraction resulting from the Plan; uncertainties relating to conditions in financial markets; currency fluctuations and foreign currency exposure; future financial performance of the industries or customers that we serve; our dependence upon revenues and earnings from a small number of significant customers; a major loss of customers; inability to realize expected sales or profits from existing backlog due to a range of factors, including changes in customer sourcing decisions, material changes, production schedules and volumes of specific programs; the impact of government budget and funding decisions; government tariffs, trade agreements and trade policies; the impact of new or revised tax laws and regulations; the adoption of laws, directives or regulations that impact the materials processed by our products or their end markets; changes in raw material or product prices and availability; the continuing impact of prior acquisitions and divestitures; integration of acquired businesses; and any other future strategic actions, including acquisitions, divestitures, restructurings, or strategic business realignments, and our ability to achieve the financial and operational targets set in connection with any such actions; the outcome of pending and future legal, governmental, or regulatory proceedings and contingencies; product liabilities and uninsured claims; future repurchases of common stock; future levels of indebtedness; and numerous other matters of a global, regional or national scale, including those of a political, economic, business, competitive, environmental, regulatory and public health nature (including the COVID-19 pandemic); and other risks and uncertainties described in documents filed with or furnished to the Securities and Exchange Commission ("SEC") by the Company, including, among others, those in the Management's Discussion and Analysis of Financial Condition and Results of Operations and Risk Factors sections of the Company's filings. The Company assumes no obligation to update its forward-looking statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

For discussion of the Company’s exposure to market risk, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Item 4. Controls and Procedures

Management, including the Company's President and Chief Executive Officer and Senior Vice President, Finance and Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company's disclosure controls and procedures as of the end of the period covered by this report. Based upon, and as of the date of, our evaluation, the President and Chief Executive Officer and Senior Vice President, Finance and Chief Financial Officer concluded that the disclosure controls and procedures were effective, in all material respects and designed to provide reasonable assurance that information required to be disclosed in the reports the Company files and submits under the Securities Exchange Act of 1934, as amended, is (i) recorded, processed, summarized and reported as and when required and (ii) is accumulated and communicated to the Company's management, including our President and Chief Executive Officer and Senior Vice President, Finance and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting during the Company's third quarter of 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

We are subject to litigation from time to time in the ordinary course of business and various other suits, proceedings and claims are pending against us and our subsidiaries. While it is not possible to determine the ultimate disposition of each of these proceedings and whether they will be resolved consistent with our beliefs, we expect that the outcome of these proceedings, individually or in the aggregate, will not have a material adverse effect on our consolidated financial position, cash flows or results of operations.

Item 1A. Risk Factors

The following represents a material change in our Risk Factors from those disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

The widespread outbreak of an illness or any other communicable disease, or any other public health crisis, has and may continue to adversely affect our business, results of operations and financial condition. We face risks related to the COVID-19 pandemic that have, and are expected to continue to have, an adverse impact on our business, results of operations and financial condition.

The COVID-19 pandemic (“COVID-19”) has negatively impacted the global economy, disrupted global supply chains and created significant volatility, uncertainty and disruption within financial markets. COVID-19 has adversely affected, and continues to pose risks to, our business, including our operational and financial performance. The extent to which COVID-19 impacts our performance depends on numerous evolving factors, many of which continue to be highly uncertain, including, among other things, the duration and spread of COVID-19, its severity, and the actions taken in response to it; the effect on our customers and customer demand for our products and services; our ability to sell and provide our products and services, including as a result of travel restrictions and “shelter in place” orders; the ability of our customers to pay for our products and services; and any closures of our offices and facilities as well as those of our customers and suppliers. Customers may also decelerate decision making, delay planned work or seek to terminate existing agreements. An extended period of global supply chain and economic disruption could materially affect our business, results of operations, access to sources of liquidity and financial condition.

Additionally, COVID-19 has had and continues to have a material impact on the air travel and aviation industries. Several countries, including the United States, have taken steps to restrict air travel, and many companies have adopted policies prohibiting non-essential business travel by their employees. Even in the absence of formal restrictions and prohibitions, contagious illness and fear of contagion have adversely affected travel behavior which may continue. Current travel restrictions, as well as changes in the propensity for the general public to travel by air as a result of COVID-19, has caused reductions in demand for commercial aircraft. If COVID-19 continues to have a material impact on the airline and aviation industry, including on General Electric, which accounted for approximately 20% of our total sales and 55% of Aerospace’s net sales in 2019, and our other large customers, it could continue to materially affect the business and results of operations of our Aerospace business.

To the extent COVID-19 or any worsening of the global business and economic environment as a result thereof continue to adversely affect our business and financial results, it may also have the effect of heightening many of the other risks described in Part I, Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for our fiscal year ended December 31, 2019.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds


Period	(a) Total Number of Shares (or Units) Purchased		(b) Average Price Paid Per Share (or Unit)		(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs	(d) Maximum Number of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs⁽²⁾
July 1-31, 2020	56,840		$	39.79	—	3,704,000
August 1-31, 2020	19,113		$	40.06	—	3,704,000
September 1-30, 2020	359		$	35.01	—	3,704,000
Total	76,312	⁽¹⁾	$	39.83	—

(1)All acquisitions of equity securities were the result of the operation of the terms of the Company's stockholder-approved equity compensation plans and the terms of the equity rights granted pursuant to those plans to pay for the related income tax upon issuance of shares. The purchase price of a share of stock used for tax withholding is the market price on the date of issuance.

(2)At March 31, 2019, 1.5 million shares of common stock had not been purchased under the publicly announced Repurchase Program (the “Program”). On April 25, 2019, the Board of Directors of the Company increased the number of shares authorized for repurchase under the Program by 3.5 million shares of common stock (5.0 million authorized, in total). The Program permits open market purchases, purchases under a Rule 10b5-1 trading plan and privately negotiated transactions.

Item 6. Exhibits


Exhibit 10.1			First Amendment, dated October 8, 2020, to Note Purchase Agreement, dated as of October 15, 2014, between the Company and the noteholders signatory thereto.
Exhibit 10.2			Amendment No. 6, dated October 8, 2020, to Fifth Amended and Restated Senior Unsecured Revolving Credit Agreement, dated as of September 27, 2011, as amended, between the Company and the lenders and other parties signatory thereto.
Exhibit 10.3			Form of Temporary Officer Base Salary Reduction Consent.
Exhibit 15			Letter regarding unaudited interim financial information.
Exhibit 31.1			Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 31.2			Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 32			Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 101.INS			XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
Exhibit 101.SCH			XBRL Taxonomy Extension Schema Document.
Exhibit 101.CAL			XBRL Taxonomy Extension Calculation Linkbase Document.
Exhibit 101.DEF			XBRL Taxonomy Extension Definition Linkbase Document.
Exhibit 101.LAB			XBRL Taxonomy Extension Label Linkbase Document.
Exhibit 101.PRE			XBRL Taxonomy Extension Presentation Linkbase Document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		Barnes Group Inc.
		(Registrant)

Date:	October 26, 2020	/s/ CHRISTOPHER J. STEPHENS, JR.
		Christopher J. Stephens, Jr. Senior Vice President, Finance Chief Financial Officer (Principal Financial Officer)

Date:	October 26, 2020	/s/ MARIAN ACKER
		Marian Acker Vice President, Controller (Principal Accounting Officer)

EXHIBIT INDEX

Barnes Group Inc.

Quarterly Report on Form 10-Q

For the Quarter ended September 30, 2020

Exhibit No.

Description

Reference

10.1

First Amendment, dated October 8, 2020, to Note Purchase Agreement, dated as of October 15, 2014, between the Company and the noteholders signatory thereto.

Incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Company on October 13, 2020.

10.2

Amendment No. 6, dated October 8, 2020, to Fifth Amended and Restated Senior Unsecured Revolving Credit Agreement, dated as of September 27, 2011, as amended, between the Company and the lenders and other parties signatory thereto.

Incorporated by reference to Exhibit 10.2 to Form 8-K filed by the Company on October 13, 2020.

10.3

Form of Temporary Officer Base Salary Reduction Consent.

Filed with this report.

Letter regarding unaudited interim financial information.

Filed with this report.

31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Filed with this report.

31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Filed with this report.

Certification pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Furnished with this report.

Exhibit 101.INS

XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

Filed with this report.

Exhibit 101.SCH

XBRL Taxonomy Extension Schema Document.

Filed with this report.

Exhibit 101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document.

Filed with this report.

Exhibit 101.DEF

XBRL Taxonomy Extension Definition Linkbase Document.

Filed with this report.

Exhibit 101.LAB

XBRL Taxonomy Extension Label Linkbase Document.

Filed with this report.

Exhibit 101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document.

Filed with this report.